Page last updated: 2024-09-04

carbapenems and Bacterial Infections, Gram-Negative

carbapenems has been researched along with Bacterial Infections, Gram-Negative in 388 studies

Research

Studies (388)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (1.55)	18.2507
2000's	54 (13.92)	29.6817
2010's	202 (52.06)	24.3611
2020's	126 (32.47)	2.80

Authors

Authors	Studies
Czech, M; Holubar, M; Ong'uti, S; Robilotti, E	1
Agarwal, A; Arshad, Z; Gupta, P; Kumari, M; Prakash, V; Siddiqui, SS; Tripathi, P; Venkatesh, V; Verma, S	1
Bassetti, M; Castaldo, N; Giacobbe, DR; Vena, A	1
Jiang, RL; Xia, GL	1
Bassetti, M; Cenderello, G; Falletta, A; Giacobbe, DR; Vena, A	1
Bassetti, M; Giacobbe, DR; Russo, C; Vena, A	1
Tenover, FC	1
Bou, G; Díaz-Regañón, J; Fariñas, MC; Fenoll, R; Ferrer, R; Gómez-Ulloa, D; Lara, N; López, D; Lozano, V; Maseda, E; McCann, E; Salavert, M	1
Russo, A; Torti, C; Trecarichi, EM	1
Chakraborty, DS; Chatterjee, S; Choudhury, S; Lahiry, S	1
Cabebe, AE; Eriguchi, Y; Hawes, C; Ouellette, AJ; Pike, K; Schaal, JB; Selsted, ME; Tran, DQ; Tran, PA; Trinh, K	1
Akova, M; Bassetti, M; Bitterman, R; Bonomo, RA; Carrara, E; Daikos, GL; de Waele, J; Gandra, S; Garnacho-Montero, J; Harbarth, S; Lindemann, PC; Mouton, JW; Paul, M; Pulcini, C; Retamar, P; Rodríguez-Baño, J; Seme, K; Tacconelli, E; Tängdén, T; Tumbarello, M; Yu, Y	1
Bassetti, M; Echols, R; Ferrer, R; Lodise, TP; Naas, T; Niki, Y; Paterson, DL; Zeitlinger, M	1
Alves, EG; da Costa Lamounier, TA; de Araújo, WN; de Castro E Caldo Lima, GR; de Oliveira, PM; Faria-Junior, C; Haddad, R; Pereira, AL	1
Abdissa, S; Bosselmann, M; Feldt, T; Fuchs, A; Häussinger, D; Hurissa, Z; Luedde, T; Mackenzie, CR; Nordmann, T; Orth, HM; Pfeffer, K; Schönfeld, A; Tufa, TB; Wienemann, T	1
Fortaleza, CMCB; Leite, GS; Oliveira, JDS; Pereira, MADM; Sampaio, NCFM	1
Abdul-Aziz, MH; Bassetti, M; de Montmollin, E; Giacobbe, DR; Roberts, JA; Timsit, JF	1
Agakidou, E; Antachopoulos, C; Darda, VM; Iosifidis, E; Kirvasilis, F; Papakonstantinou, E; Roilides, E; Sdougka, M; Simitsopoulou, M; Zarras, C	1
Biswas, NR; Katiyar, A; Kaur, P; Kumar, A; Kumar, B; Kumar, M; Kumari, N; Priya, P	1
Cruz-López, F; Garza-González, E; Maldonado-Garza, HJ; Martínez-Meléndez, A; Morfin-Otero, R; Rodriguez-Noriega, E	1
Albur, M; Barlow, G; Dodgson, AR; Enoch, DA; Gill, K; Goldenberg, SD; Jones, L; Longshaw, C; Lopes, S; Manissero, D; Marek, A; Micallef, C; Parcell, BJ; Wilson, APR	1
Chen, J; Chen, Y; Huang, M; Liang, Q; Xu, Y	1
Feng, S; Wang, H; Zhen, S	1
Bassetti, M; Kanj, SS; Kiratisin, P; Rodrigues, C; van Duin, D; Villegas, MV; Yu, Y	1
Badia, X; Cantón, R; Del Pozo, JL; Ferrer, R; García-Vidal, C; Garnacho-Montero, J; Giró-Perafita, N; Larrosa, N; Pintado, V; Rascado, P; Salavert, M; Soriano, A	1
Betthauser, KD; Hetzler, L; Kollef, MH; Micek, ST; Yuenger, V	1
Cabañero-Navalón, MD; Garcia-Bustos, V; Salavert Lletí, M	1
Maseda, E; Suárez de la Rica, A	1
Clancy, CJ; Nguyen, MH	1
Brink, AJ; Prentice, E; Richards, G; Tootla, H	1
Assanelli, AA; Bernardi, M; Carletti, S; Carrabba, MG; Castagna, A; Ciceri, F; Clerici, D; Corti, C; Erbella, F; Farina, F; Galli, L; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Lugli, AP; Lupo Stanghellini, MT; Mancini, N; Mastaglio, S; Nitti, R; Oltolini, C; Peccatori, J; Poli, A; Ripa, M; Ruggeri, A; Scarpellini, P; Tassan Din, C; Xue, E	1
Li, W; Liu, K; Liu, Y; Sun, J; Xu, H	1
Christaki, E; Cross, ELA; Del Toro, MD; Eckmann, C; Friedrich, AW; Giannella, M; Guirao, X; Kluytmans, J; Mutters, NT; Presterl, E; Righi, E; Sganga, G; Tacconelli, E; Tsioutis, C; Visentin, A	1
Badia, X; Barral, P; Cantón-Bulnes, L; Contreras, S; Del Cerro, I; Ferrer, R; Garnacho-Montero, J; Rascado, P	1
Biehl, LM; Ket, JCF; Remmelzwaal, S; van Dijk, K; Vandenbroucke-Grauls, CMJE; Vehreschild, MJGT; Willems, RPJ	1
Chamilos, G; Ioannou, P; Kofteridis, DP; Kritsotakis, EI; Mathioudaki, A; Petrodaskalaki, M; Spanias, C; Spernovasilis, N; Vouidaski, A	1
Chen, X; Feng, Z; Liao, Q; Lin, H; Lin, J; Zhou, Y; Zhuo, H	1
Bilen, NM; Cilli, F; Güner Özenen, G; Kurugöl, Z; Ozdemir Karadas, N; Ozek, G; Sahbudak Bal, Z; Yazici, P; Yildirim Arslan, S	1
Ardebili, A; Izanloo, A; Rastegar, M	1
König, E; Zollner-Schwetz, I	1
Chen, B; Chen, D; Chen, Y; Guan, X; Hu, B; Hu, F; Huang, X; Li, J; Li, X; Li, Y; Liu, Z; Lv, X; Ni, Y; Qiu, H; Qu, J; Ren, J; Shi, Y; Wang, J; Wang, M; Wu, A; Wu, D; Xia, J; Xu, Y; Yang, F; Yang, Q; Yang, W; Yu, Y; Zeng, M; Zhang, J; Zhou, H; Zhuo, C; Zong, Z	1
Bonomo, RA; Calvopiña, K; Dmitrienko, GI; Hinchliffe, P; Mojica, MF; Rabe, P; Schofield, CJ; Spencer, J; Vila, AJ	1
Carmona, P; Córdoba-Fernández, M; de la Fuente, C; Domínguez, A; García, L; Guzmán-Puche, J; López-Viñau, T; Machuca, I; Martínez-Martínez, L; Merino, N; Robles, JC; Rodríguez, M; Torre-Cisneros, J; Vaquero, JM	1
Antachopoulos, C; Darda, VM; Haidich, AB; Iosifidis, E; Kirvasilis, F; Kontou, A; Papakonstantinou, E; Roilides, E; Sdougka, M; Zarras, C	1
Chen, Y; Hu, Q; Liu, YP; Long, WM; Qu, J; Qu, Q; Wang, Q; Wu, XL; Xiao, YW; Xu, TT; Zhuang, HH	1
Cao, Y; He, LY; Lu, GP; Wang, CQ; Wang, LS; Yin, LJ; Zhai, XW	1
Aiqin, L; Wenwen, S; Xiquan, L	1
Anderson, AJ; Burton, T; Dillon, R; Puzniak, L; Seare, J	1
Shah, BK; Wang, C; Wang, J; Xie, S; Xiong, J; Zhao, J	1
Hu, C; Liu, Y; Lv, X; Qu, J; Xu, J; Zhong, C	1
Chen, WC; Cheng, HY; Hung, CC; Lin, MH; Lin, YC; Shen, YC; Teng, CK	1
Accordini, S; Azzini, AM; Bazaj, A; Be, G; Coledan, I; Lambertenghi, L; Lo Cascio, G; Mazzaferri, F; Miotti, J; Mirandola, M; Naso, L; Salerno, ND; Tacconelli, E	1
Acevedo, J; Araos, R; D'Agata, EMC; Ferreccio, C; González, M; Huidobro, LA; Jara, A; Khan, A; Maureira, L; Munita, JM; Paredes, C; Park, BJ; Peters, A; Rioseco, ML; Rivas, L; Sánchez, F; Sepulveda, D; Smith, RM; Soto, PR; Spencer-Sandino, M; Styczynski, A; Undurraga, E; Usedo, P; Wettig, LR	1
Bezerra, CLPAM; Boszczowski, I; Dias, MBS; Dos Santos, EL; Freire, MP; Levin, AS; Oliveira, MS; Salomão, MC	1
Fang, C; Li, J; Zhou, M; Zhou, Z	1
Bae, S; Cho, K; Han, H; Jung, J; Kim, EO; Kim, J; Kim, SH; Lee, SO; Park, I; Son, HJ	1
Aguado Ventura, C; Alpaca-Salvador, HA; Amaro, C; Astocondor, L; Barco-Yaipén, E; Bocangel Fernandez, C; Briones, A; Burgos, A; Campana, R; Castañeda-Sabogal, A; Castillo, K; Chincha, O; Coaquira, A; Concha-Velasco, F; Cuadros, EC; Díaz Sipión, R; Diaz, JC; Fernandez, V; García, C; Hinostroza, N; Hueda-Zavaleta, M; Ingelbeen, B; Jacobs, J; Krapp, F; López, E; Paricahua Peralta, E; Peralta Córdova, T; Pino-Dueñas, JE; Rondon, CR; Sarmiento Lopez, F; Sierra Chavez, E; Sullón Zavaleta, PA; Valera-Krumdieck, M; Vásquez, R; Vidaurre Torres, AM; Villegas-Chiroque, M	1
Caseris, M; Cohen, R; Dortet, L; Lorrot, M; Raymond, J; Toubiana, J	1
Bartolini, A; Bartoloni, A; Bernardo, M; Bianco, V; Botta, A; Faragona, A; Giacometti, A; Giani, T; Graziani, L; Lagi, F; Morroni, G; Parrella, R; Piccica, M; Rossolini, GM; Spinicci, M; Tavio, M	1
Baum, K; Bonomo, RA; Doi, Y; Evans, SR; Fowler, VG; Hamasaki, T; Komarow, L; Lodise, TP; Patel, R; Rodvold, KA; Rouphael, N; Satlin, MJ; Schwager, N; Souli, M; Tamma, PD; van Duin, D; Van Tyne, D	1
Campos, J; Diaz Högberg, L; Eckmanns, T; Giske, CG; Grundmann, H; Heuer, OE; Jarlier, V; Johnson, AP; Kahlmeter, G; Monen, J; Monnet, DL; Pantosti, A; Rossolini, GM; Simonsen, GS; van de Sande-Bruinsma, N; Vatopoulos, A; Żabicka, D; Žemličková, H	1
Dela Cruz, CM; Shettima, SA; Tenover, FC; Tickler, IA	1
Coppola, N; Di Caprio, G; Onorato, L; Signoriello, S	1
Cotta, MO; Dulhunty, JM; Eriksson, L; Harris, P; Malacova, E; Milinovich, GJ; Vickers, ML	1
Beyene, D; Bitew, A; Evans, M; Fantew, S; Mihret, A	1
Brink, AJ	1
Bouza, E; Burillo, A; Muñoz, P	1
Carroll, KC; Chambers, KK; Goodman, K; Kazmi, AQ; Lewis, S; Milstone, AM; Opene, BNA; Simner, PJ; Tamma, PD; Wang, R; Workneh, M	1
Chen, F; Chen, X; Deng, Y; Han, L; Pang, X; Qian, Y; Shen, C; Xia, Q; Zhang, J; Zhang, Z	1
Baier, C; Bange, FC; Beck, M; Beutel, G; Bollin, R; Ebadi, E; Eder, M; Hintze, SC; Kharazipour, D; Lueck, C; Panagiota, V; Ziesing, S	1
Bell, D; Humphries, R; McKinnell, JA; Miller, L; Needleman, J; Richter, SE; Uslan, DZ; Watson, K	1
Asmara, W; Dwiprahasto, I; Mulyono, B; Sianipar, O	1
Doi, Y	1
Nordmann, P; Poirel, L	1
Pal, A; Tripathi, A	1
Harris, PNA; Henderson, A; Paterson, DL	1
Aguilera-Alonso, D; Baquero-Artigao, F; Cercenado, E; Escosa-García, L; Saavedra-Lozano, J	1
Anastassiou, ED; Assimakopoulos, SF; Christofidou, M; Fligou, F; Karamouzos, V; Kolonitsiou, F; Marangos, M; Papachristou, E; Papadimitriou-Olivgeris, M; Solomou, A; Spiliopoulou, I; Spyropoulou, A; Vamvakopoulou, S	1
Benezit, F; Camus, C; Fillatre, P; Le Tulzo, Y; Massart, N; Moriconi, M	1
Dudeja, S	1
Chang, JS; Chien, HT; Hsieh, KP; Lin, YC; Sheu, CC	1
Abad, CLR; Li, KL	1
Cho, SY; Chung, DR; Ha, YE; Huh, HJ; Huh, K; Kang, CI; Kim, MJ; Kim, SH; Ko, JH; Lee, NY; Peck, KR; Song, JH	1
Calil, FF; de Azevedo Carazatto, PZ; Fortaleza, CMCB	1
Cao, Y; Chen, L; Chen, T; Liu, H; Wang, L; Yang, C; Zhou, W	1
Adam, HJ; Baxter, M; Golden, AR; Karlowsky, JA; Lagacé-Wiens, P; Walkty, A; Zhanel, GG	1
Gupta, V; McCann, E; Sung, A; Tabak, YP; Vankeepuram, L; Ye, G	1
Andini, R; Antoniadou, A; Bitterman, R; Brill, MJE; Carmeli, Y; Daikos, GL; Daitch, V; Dishon-Benattar, Y; Durante-Mangoni, E; Eliakim-Raz, N; Friberg, LE; Karlsson, MO; Kotsaki, A; Kristoffersson, AN; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Rognås, V; Skiada, A; Theuretzbacher, U	1
Bernardo, M; Bitterman, R; Carmeli, Y; Daikos, G; Daitch, V; Dishon-Benattar, Y; Durante-Mangoni, E; Friberg, LE; Iossa, D; Leibovici, L; Lellouche, J; Mouton, JW; Nutman, A; Paul, M; Skiada, A; Temkin, E; Theuretzbacher, U; Yahav, D; Zusman, O	1
Chen, Y; Jiang, S; Lu, X; Shen, P; Xiao, Y; Yang, P	2
Bosso, JA; Davis, SL; Goff, DA; Rhodes, NJ; Rybak, MJ; Scheetz, MH; Wagner, JL	1
Choe, PG; Hong, JS; Jun, KI; Kang, CK; Kim, I; Kim, NJ; Kim, TS; Koh, Y; Oh, MD; Park, J; Park, S; Park, WB; Shin, DH; Shin, DY; Yoon, SS	1
Adams, ER; Cuevas, LE; Edwards, T; Evans, K; Hobbs, G; Sasaki, S; Sealey, J; Teethaisong, Y; Williams, C	1
Alhmidi, H; Bonomo, RA; Cadnum, JL; Donskey, CJ; Jencson, AL; Koganti, S; Mayer, J; Samore, MH; Wilson, BM	1
Cai, Y; Li, YY; Wang, J; Wang, R	1
Fredricks, DN	1
Aitken, SL; Ajami, NJ; Arias, CA; Galloway-Peña, JR; Kontoyiannis, DP; Sahasrabhojane, PV; Savidge, TC; Shelburne, SA	1
Abbo, L; Claeys, KC; De Pascale, B; Jimenez, A; Martinez, OV; Perez-Cardona, A; Rosello, G; Vega, AD	1
Badia, X; Cantón, R; González, J; Huarte, R; Morata, L; Muñoz, R; Tort, M; Trillo-Mata, JL	1
Cao, X; Chang, H; Chen, S; Chen, Y; Hao, Y; Huang, R; Jia, B; Wu, C; Wu, W; Xiong, Y; Yan, X; Zhang, H; Zhang, Z; Zhou, W	1
Board, MM; Crespo, R; Faux, C; Guard, J; Paul, NC; Shah, DH	1
Breitwieser, FP; Dien-Bard, J; Hao, S; Opene, BNA; Simner, PJ; Tamma, PD; Timp, W; Workman, RE; Yee, R	1
Alves, MZO; Asensi, MD; Bandeira, CS; Beck, DS; Cid, PA; Gomes Junior, SCS; Gomes, MZR; Lima, EM; Lourenço, ND; Marques, JA; Pinheiro, LHZ; Rodrigues, CAS; Santos, RQ; Tonhá, JPS	1
Fasshold, L; Goessler, W; Holl, AM; Kühn, KD; Schmid, M; Steiner, O	1
Harris, P; Isler, B; Kidd, TJ; Paterson, DL; Stewart, AG	1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y	1
Becker, K; Gysin, M; Haldimann, K; Hobbie, SN; Plattner, M	1
Gikas, A; Karakonstantis, S; Kritsotakis, EI	1
Lai, CC; Tang, HJ; Wang, JH	1
Babiker, A; Clancy, CJ; Clarke, LG; Gealey, JA; Nguyen, MH; Saul, M; Shields, RK	1
Kois, AK; Kuti, JL; Nicolau, DP	1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A	1
Bakthavatchalam, YD; Dwarakanathan, HT; Nadarajan, A; Soman, R; Veeraraghavan, B; Venkatasubramanian, R	1
Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG	1
Cai, B; Hsu, WC; Kanakamedala, H; Lodise, TP	1
Giannella, M; Longshaw, C; Lopes, S; Manissero, D; McCool, R; Palacios-Baena, ZR; Rodríguez-Baño, J; Viale, P; Wilson, K	1
Carniel, E; Dias, CG; Narvaez, GA; Perez, LRR	1
Hu, F; Jia, P; Jin, X; Li, M; Qin, X; Tang, YW; Tenover, FC; Wu, S; Yang, Q; Yu, Y; Zhang, H	1
Avendano, EE; Chan, J; McCann, E; Raman, G	1
Bedos, JP; Daikos, G; Dodgson, AR; Ferrer, R; Pan, A; Petrosillo, N; Seifert, H; Vila, J; Wilson, P	1
Bisnauthsing, K; Goldenberg, SD; Merrick, B; Tan, MKI	1
Avcu, G; Cilli, F; Guner Ozenen, G; Kurugol, Z; Ozkinay, F; Sahbudak Bal, Z; Tekin, D; Umit, Z	1
Bechstein, WO; Ferstl, PG; Filmann, N; Heilgenthal, EM; Hogardt, M; Kempf, VAJ; Mücke, MM; Mutlak, H; Schnitzbauer, AA; Schultze, TG; Stephan, C; Trebicka, J; Villinger, D; Waidmann, O; Weiler, N; Welker, MW; Zeuzem, S	1
Feng, C; Li, H; Lv, X; Qu, J	1
Chan, MC; Chen, CM; Feng, JY; Lin, YC; Lin, YT; Peng, CK; Shen, YC; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR	1
Kyany'a, C; Maybank, R; Musila, L; Oundo, V; Sang, W; Stam, J	1
Babar, ZU; Dodani, SK; Nasim, A	1
Aguirre-Burciaga, E; Alavez-Ramírez, N; Avalos-Aguilera, AM; Aviles-Benitez, LK; Barajas-Magallón, JM; Barlandas-Rendón, NRE; Barrios-Camacho, H; Bello-Pazos, FD; Bobadilla-Del-Valle, M; Bocanegra-Ibarias, P; Bolado-Martínez, E; Cabriales-Zavala, JF; Camacho-Ortiz, A; Canizales-Oviedo, JL; Cetina-Umaña, CM; Choy-Chang, EV; Cobos-Canul, DI; Colin-Castro, CA; Esteban-Kenel, V; Feliciano-Guzmán, JM; Flores-Treviño, S; Fong-Camargo, MG; Franco-Cendejas, R; Galindo-Méndez, M; García-Mendoza, L; García-Romo, R; Garza-González, E; Garza-Ramos, U; Gil-Veloz, M; Guerrero-Núñez, AE; López-García, M; López-Gutiérrez, E; López-Jácome, LE; López-Moreno, LI; Maldonado-Anicacio, JY; Martínez-Villarreal, RT; Mena-Ramírez, JP; Méndez-Sotelo, BJ; Morales-De-la-Peña, CT; Moreno-Méndez, MI; Morfín-Otero, R; Nava-Pacheco, YC; Ortiz-Porcayo, AE; Ostos-Cantú, HL; Perez-Vicelis, T; Ponce-de-León-Garduño, LA; Rojas-Larios, F; Romero-Romero, D; Rosales-García, AA; Santiago-Calderón, MA; Silva-Gamiño, AR; Silva-Sánchez, J; Valero-Guzmán, J; Vázquez-Larios, MDR; Velázquez-Acosta, MDC	1
Bernardi, M; Castagna, A; Castiglion, B; Ciceri, F; Clerici, D; Corti, C; Farina, F; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Mastaglio, S; Oltolini, C; Pavesi, F; Peccatori, J; Ripa, M; Scarpellini, P; Tassan Din, C	1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E	1
Altayb, HN; Elbadawi, HS; Elhag, KM; Elton, L; Hamid, MMA; Ippolito, G; Mahgoub, E; McHugh, TD; Ntoumi, F; Osman, AY; Tembo, J; Zumla, A	1
Bragantini, D; Brink, AJ; Carrara, E; Chiamenti, M; Ellis, S; Franceschi, F; Giske, C; Gorska, A; Harris, PNA; Levy-Hara, G; Piddock, LJV; Righi, E; Rohit, A; Savoldi, A; Sharland, M; Tacconelli, E; Tsioutis, C; Zayyad, H	1
Liang, C; Meng, G; Peng, P; Zhang, X; Zhong, L; Zhou, L	1
Bragantini, D; Carrara, E; Chiamenti, M; Ellis, S; Franceschi, F; Piddock, LJV; Righi, E; Savoldi, A; Tacconelli, E	1
Dela Cruz, CM; Dewell, S; Le, VM; Shettima, SA; Sumner, J; Tenover, FC; Tickler, IA	1
Bergman, Y; Carroll, KC; Chambers, KK; Fisher, S; Simner, PJ; Tamma, PD; Yee, R	1
Rhoads, DD	1
Bernard Fourie, P; Osei Sekyere, J; Reta, MA	1
Falagas, ME; Legakis, NJ; Skalidis, T; Vardakas, KZ	1
Brandt, C; Ferstl, PG; Filmann, N; Hogardt, M; Kempf, VAJ; Müller, M; Reinheimer, C; Waidmann, O; Zeuzem, S	1
Wilson, APR	1
Andrews, B; Bifulco, N; Carter, NM; Chen, B; Comita-Prevoir, J; de Jonge, B; Durand-Réville, TF; Ehmann, DE; Gao, N; Giacobbe, RA; Guler, S; Huynh, H; Lahiri, S; McLaughlin, R; McLeod, SM; Miller, AA; Moussa, SH; Mueller, JP; Newman, JV; O'Donnell, J; Olivier, NB; Palmer, T; Shapiro, AB; Thresher, J; Tommasi, RA; Velez-Vega, C	1
Ahmed, MO; Almshawt, N; Elramalli, A	1
Chong, CY; Lim, ASY; Ong, RYL; Seah, VXF; Tan, NWH; Thoon, KC	1
Lee, CH; Liu, JW; Ting, SW	1
Aizawa, Y; Fukuoka, K; Furuichi, M; Higuchi, H; Horikoshi, Y; Ito, K; Kaneko, T; Okazaki, K; Shoji, T; Suwa, J	1
Avcu, G; Aydemir, S; Bekmezci, N; Sahbudak Bal, Z; Sen, S; Soylu, M; Vardar, F	1
Bandettini, R; Cangemi, G; Castagnola, E; Faraci, M; Gattorno, M; Loy, A; Mesini, A; Moscatelli, A	1
Acker, EC; Al-Hasan, MN; Bookstaver, PB; Justo, JA; Kohn, JE	1
Cho, SY; Chung, DR; Ha, YE; Huh, K; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Seok, H; Song, JH	1
Reyes, S; Schuetz, AN; Tamma, PD	1
Akalın, H; Alışkan, HE; Aydın, G; Aydın, M; Azap, A; Azap, Ö; Başaran, S; Bilgin, H; Çakar, ŞE; Can, F; Çavuş, SA; Demir, NA; Demirkaya, H; Demiroğlu, YZ; Erdinç, Ş; Ergen, P; Ergönül, Ö; Hatipoğlu, Ç; Karakoç, Ç; Karaoğlan, I; Kaya, Ş; Keske, Ş; Memikoğlu, O; Menekşe, Ş; Mülazımoğlu, L; Tekin, S; Tezer, Y; Tümtürk, A; Ural, O; Yardımcı, C; Yılmaz, E	1
Aubry, A; Charles-Nelson, A; Compain, F; Dépret, F; Fernandez-Gerlinger, MP; Fournier, A; Katsahian, S; Mainardi, JL	1
Cienfuegos-Gallet, AV; Higuita-Gutiérrez, LF; Jiménez Quiceno, JN; López-López, L; Vargas-Alzate, CA	1
Ayubi, E; Safiri, S	1
Sahbudak Bal, Z	1
Beović, B; Daikos, GL; Durante-Mangoni, E; Kaye, KS; Papst, L; Paul, M; Pulcini, C; Raka, L; Rodríguez-Baño, J	1
Kim, YA; Park, YS	1
Demir, C; Keşli, R	1
Asar, L; Both, A; Katchanov, J; Kluge, S; Klupp, EM; König, C; Maurer, FP; Rohde, H; Rothe, C	1
Britt, NS; Burnham, CD; Durkin, MJ; Hampton, NB; Kollef, MH; Micek, ST; Ritchie, DJ	1
Andini, R; Antoniadou, A; Carmeli, Y; Cavezza, G; Daikos, GL; Dishon Benattar, Y; Durante-Mangoni, E; Eliakim-Raz, N; Leibovici, L; Nutman, A; Paul, M; Pfeffer, I; Skiada, A; Yahav, D; Zak-Doron, Y	1
Antachopoulos, C; Gritsi-Gerogianni, N; Iosifidis, E; Karampatakis, T; Karapanagiotou, A; Karyoti, A; Roilides, E; Tsakris, A; Tsergouli, K	1
Canton, R; Carretto, E; Moore, NM; Traczewski, MM	1
Cheng, C; Li, S; Lu, W; Rui, Y; Sun, J; Yang, Q	1
Cui, M; Gao, Y; Gu, ZC; Zhang, C; Zhang, ZL; Zhao, XY; Zhong, H	1
Jain, A; Parr, TR; Pucci, MJ; Utley, L; Zabawa, T	1
Adjemian, J; Danner, RL; Dekker, JP; Fridkin, S; Hooper, DC; Kadri, SS; Klompas, M; Lai, YL; Palmore, TN; Powers, JH; Prevots, DR; Rhee, C; Ricotta, E; Spaulding, AB; Suffredini, AF	1
Fan, W; Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD	2
Bassetti, M; Giamarellos-Bourboulis, EJ; Graziano, E; Kotsaki, A; Righi, E; Routsi, C	1
Armin, S; Azimi, L; Fallah, F; Ghazvini, K; Hasanzadeh, S; Karimi, A; Samadi Kafil, H	1
Huang, YC; Lin, YT; Wang, FD; Wu, PF	1
Hwang, H; Kim, B	1
Fujita, J; Hishinuma, T; Kirikae, T; Nakama, M; Nakasone, I; Sawachi, Y; Tada, T; Takaesu, R; Uechi, K	1
Alvares, PA; Arnoni, MV; da Silva, CB; Mimica, MJ; Sáfadi, MAP	1
Abrar, S; Ain, NU; Bukhari, SS; Haider, MH; Hussain, S; Iftikhar, A; Rasheed, F; Riaz, S	1
Bădițoiu, L; Bagiu, IC; Coșniță, DA; Dugăeşescu, D; Dumitrașcu, V; Horhat, DI; Horhat, FG; Krasta, A; Licker, M; Muntean, D	1
Gupta, V; McCann, E; Sung, AH; Tabak, YP; Vankeepuram, L; Ye, G	1
Naber, KG; Wagenlehner, FME	1
Adam, MA; Elhag, WI	1
Galani, I; Giamarellou, H; Karaiskos, I; Souli, M	1
Del Giacomo, P; Losito, AR; Tumbarello, M	1
Berberian, G; Brizuela, M; Castro, G; Fiorili, G; Mastroiani, A; Reijtman, V; Rosanova, MT; Santa Cruz, D; Travaglianti, M	1
Adam, HJ; Domalaon, R; Golden, AR; Idowu, T; Karlowsky, JA; Lagacé-Wiens, PRS; Lawrence, CK; Lynch Iii, JP; Noreddin, A; Schweizer, F; Walkty, AJ; Wiebe, K; Zelenitsky, S; Zhanel, GG; Zhanel, MA	1
Alharbi, A; Alshehri, S; Eljaaly, K; Ortwine, JK; Pogue, JM	1
Benzerara, Y; Compain, F; Constant, AL; Gallah, S; Garnier, M; Guerot, E; Labbe, V; Mainardi, JL; Montil, M; Quesnel, C; Siami, S; Vimont, S	1
Hsu, AJ; Tamma, PD	2
Venter, H	1
Demord, A; Mueller, L; Nordmann, P; Ottiger, C; Poirel, L	1
Abdallah, M; Alharthy, A; Alzaagi, I; Badawi, M; Issa, KN; Rasheed, A	1
Andrade, RM; Bozza, FA; Dalmas, B; Dantas, LF; Hamacher, S	1
Bhagwati, G; Bhakuni, P; Chakrabarti, A; Chakrabarti, S; Jaiswal, SR; Joy, A	1
Codjoe, FS; Donkor, ES; Miller, K; Smith, TJ	1
Antachopoulos, C; Iosifidis, E; Karampatakis, T; Karyoti, A; Mouloudi, E; Roilides, E; Tsakris, A; Tsergouli, K	1
Dortet, L; Emeraud, C; Fournier, D; Naas, T; Plésiat, P; Potron, A; Triponney, P	1
Azougagh, K; Barbier, F; Boulain, T; Boutrot, M; Guinard, J	1
Leibovici, L; Paul, M; Zusman, O	1
Apisarnthanarak, A; Hsu, LY; Khawcharoenporn, T; Mundy, LM	1
Falagas, ME; Kapaskelis, A; Tansarli, GS; Vardakas, KZ	1
Bell, JM; Gillespie, EE; Korman, TM; Kotsanas, D; Li, HY; Snook, K; Stuart, RL; Wijesooriya, WR; Williams, N; Wright, L	1
Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsueh, PR; Jean, SS; Ko, WC; Lam, C; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW	1
Hiramatsu, K; Kikuchi, K; Matsuda, M; Notake, S; Tamai, K; Yanagisawa, H	1
Nanas, S; Papas, V; Pitsiolis, T; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Sotiropoulou, C; Tsakris, A	1
Kemper, AL; Young, DC; Zobell, JT	1
Bracco, S; Brigante, G; Corbo, N; Luzzaro, F; Micheletti, P; Migliavacca, R; Nucleo, E; Piazza, A; Pini, B	1
Grover, N; Khajuria, A; Kumar, M; Praharaj, AK	1
Balkhy, HH; Paterson, DL; Walsh, TR; Zowawi, HM	1
Gardner, J; Toledo-Pereyra, LH; Zaffiri, L	1
Baserni, MN; Jugo, MB; Villar, HE	1
Kanafani, ZA; Kanj, SS; Kmeid, JG; Youssef, MM	1
Bulitta, JB; Landersdorfer, CB; Zavascki, AP	1
Chlebicki, MP; Kwa, AL; Lee, AL; Lee, W; Liew, LT; Lim, CL; Nah, SC; Wan, CN	1
Changawala, N; Chapnick, E; Crusio, R; Kupfer, Y; Paul, V; Rao, S; Tiu, C; van Ginkel, J	1
Apisarnthanarak, A; Bhooanusas, N; Mundy, LM; Yaprasert, A	1
Chiang, MC; Chu, SM; Fu, RH; Hsu, JF; Huang, HR; Huang, YC; Lee, CW; Lien, R; Tsai, MH	1
Chong, YP; Choo, EJ; Chung, JW; Jeon, MH; Kim, DM; Kim, T; Kim, YS; Lee, HK; Moon, C; Park, SY; Peck, KR	1
Ogbolu, DO; Webber, MA	1
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI	1
Doumith, M; Hill, R; Hopkins, KL; Jain, A; Livermore, DM; Loy, R; Meunier, D; Pike, R; Turton, J; Woodford, N	1
Carmeli, Y; Durante-Mangoni, E; Leibovici, L; Mouton, JW; Mussini, C; Paul, M; Tacconelli, E; Theuretzbacher, U	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT	1
Blanco, VM; Correa, A; Hernández-Gómez, C; Motoa, G; Vallejo, M; Villegas, MV	1
Caio, C; Cormaci, R; Denaro, C; Gennaro, M; Gona, F; Mezzatesta, ML; Quattrone, C; Salerno, I; Stefani, S; Zingali, T	1
Ageevets, VA; Ilina, EN; Lisitsyna, ES; Lobzin, YV; Partina, IV; Shlyapnikov, SA; Sidorenko, SV	1
Bonne, SL; Christopher, KB; Danner, RL; Hohmann, SF; Hooper, DC; Kadri, SS; Moffa, MA; Orav, EJ; Palmore, T; Strich, JR; Timpone, JG; Varughese, C	1
Ali, S; Baqi, S; Kalam, K; Kumar, S; Qamar, F	1
Adachi, J; Bonomo, RA; Perez, F	1
Kaye, KS; Lephart, P; Mynatt, RP; Neelakanta, A; Pogue, JM; Sharma, S	1
Behnke, M; Gastmeier, P; Geffers, C; Maechler, F; Peña Diaz, LA; Schröder, C	1
Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG	1
Cheng, C; Rui, Y; Sun, J; Zheng, F	1
Ang, B; Lew, EL; Lew, KY; Ling, LM; Lye, D; Ng, TM; Tan, M; Tan, SH; Teng, CB	1
Charlett, A; Donaldson, H; Freeman, R; Holmes, AH; Moore, LS	1
Barreto, JN; Tosh, PK; Vasoo, S	1
Kamran, R; Nahid, F; Qamar, MU; Walsh, TR; Zahra, R	1
Bootsma, HJ; Schouls, LM	1
Carmeli, Y; Costa, AN; Grossi, PA; Ippolito, G; Ison, MG; Lanini, S; Procaccio, F; Puro, V; Ricci, A; Vesconi, S; Vespasiano, F	1
Bass, SN; Bauer, SR; Lam, SW; Neuner, EA	1
Bertani, A; Campanella, M; Conaldi, P; Gona, F; Gridelli, B; Grossi, P; Gruttadauria, S; Luca, A; Mularoni, A; Spada, M; Vitulo, P; Vizzini, G	1
Bozdogan, B; Gothandam, KM; Manohar, P; Maray, S; Nachimuthu, R; Sivamangala, K; Subramani, R	1
Andria, N; Domchenko, A; Fraser, D; Henig, O; Kotler, O; Ofran, Y; Oren, I; Paul, M; Zuckerman, T	1
Giannella, M; Lewis, R; Tedeschi, S; Viale, P	1
Denkel, LA; Gastmeier, P; Layer, F; Leistner, R; Pfeifer, Y; Werner, G	1
Boyle, DP; Zembower, TR	1
Abd Rahman, AN; Abdul-Aziz, MH; Lipman, J; Mat-Nor, MB; Roberts, JA; Staatz, CE; Sulaiman, H; Wallis, SC	1
Kaye, KS; Pogue, JM	1
Bass, SN; Bauer, SR; Gibson, GA; Lam, SW; Neuner, EA	1
Altinkanat Gelmez, G; Bakir, M; Karaaslan, A; Kepenekli Kadayifci, E; Söyletir, G; Soysal, A	1
Shah, PG; Shah, SR	1
Rodrigues, C; Shetty, A; Soman, R	1
Huang, ZG; Xu, A; Xu, YC; Zheng, B; Zhong, NS; Zhuo, C	1
Lee, JY; Lertharakul, T; Miglis, CM; O'Donnell, JN; Scheetz, MH; Tuvell, M	1
Anuj, SN; Bergh, H; George, NM; Heney, C; Nimmo, GR; Paterson, DL; Sidjabat, HE; Sinclair, HA	1
Mustapha, A; Pfeifer, Y; Singh, P	1
Chukwuma, U; Clifford, R; Gierhart, S; Hinkle, M; Lesho, E; Neumann, C; Richesson, D; Sparks, M; Waterman, P	1
Carroll, KC; Martin, I; Milstone, AM; Opene, B; Simner, PJ; Tamma, PD	1
Fransén, J; Hanberger, H; Huss, FR; Nilsson, LE; Rydell, U; Sjöberg, F	1
Bastos, AN; Bastos, LQ; Bastos, VQ; Da Silva, VL; Dias, VC; Diniz, CG; Peter, AC	1
Al-Masaudi, S; Elawady, S; Elsherif, R; Harakeh, S; Ismail, D; Jastaniah, S; Karrouf, G	1
Clarkson, L; Hanberger, H; Hf, W; Hoang, BTN; Khu, DTK; Lam, YM; Larsson, M; Le, HT; Le, NK; Nadjm, B; Nguyen, KV; Nguyen, TH; Nilsson, LE; Rydell, U; Thai, TQ; Vo, VT; Vu, DTV; Vu, PD	1
El Salabi, AA; Elahmer, O; Ghenghesh, KS; Kraiem, AG; Zorgani, A	1
Wilson, AP	1
Mayor, S	1
Bartoletti, M; Cavina, A; Cristini, F; Giannella, M; Liverani, A; Pederzini, R; Pignanelli, S; Tedeschi, S; Toni, L; Trapani, F; Tumietto, F; Viale, P	1
Altunin, S; Benattar, YD; Daitch, V; Elbaz, M; Granot, M; Leibovici, L; Omar, M; Paul, M; Yahav, D; Zak-Doron, Y; Zusman, O	1
Harris, PN; Lane, SW; Liborio, M; Paterson, DL; Peri, AM; Righi, E; Wailan, AM	1
Aykac, K; Basaranoglu, ST; Cengiz, AB; Ceyhan, M; Kara, A; Karahan, S; Ozsurekci, Y; Sancak, B	1
Ebara, H; Hagiya, H; Haruki, Y; Kondo, E; Otsuka, F	1
Adil, S; Habib, F; Hasan, R; Idrees, F; Irfan, S; Mehraj, V	1
Friedland, I; Jasovich, A; Jiang, J; Kaniga, K; Lucasti, C; Umeh, O	1
Brown, NP; Pillar, CM; Sahm, DF; Shah, D; Torres, MK	1
Basso, M; Costa, SF; Gobara, S; Gomez, LB; Levin, AS; Oshiro, I; Paez, JG; Spadão, F	1
Haldorsen, B; Lundblad, EW; Samuelsen, O; Simonsen, GS; Sundsfjord, A	1
Castanheira, M; Jones, RN; Livermore, DM	1
Bell, JM; Jones, RN; Sader, HS; Stilwell, MG; Turnidge, JD	1
Dedhia, HV; McKnight, R	1
Rahal, JJ	2
Giamarellou, H; Poulakou, G	2
Overturf, GD	1
Devasahayam, G; Hoffman, PS; Scheld, WM	1
Cornaglia, G; Rossolini, GM	1
Akova, M; Carmeli, Y; Cornaglia, G; Daikos, GL; Garau, J; Giamarellou, H; Harbarth, S; Rossolini, GM; Souli, M	1
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC	1
Aldous, WK; Co, EM	1
Appelbaum, PC; Credito, K; Kosowska-Shick, K	1
Flamm, R; Kaniga, K; Nandy, P; Samtani, MN	1
Amsler, K; Bush, K; Flamm, R; Foleno, B; Santoro, C	1
Lumb, J	1
Cohen, R; Durrmeyer, X	1
Cassettari, M; Chongthaleong, A; Christiansen, KJ; Cooper, D; Flamm, R; Garcia, J; Hsu, L; Ip, M; Ker, HB; Kiratisin, P; Mendoza, M; Morrissey, I; Okolo, P; Quintana, A; Redjeki, IS	1
Ko, KS; Lee, H; Peck, KR; Song, JH	1
Armand-Lefevre, L; Drugeon, HB; Gjoklaj, M; Kitzis, MD; Lascols, C; Leclercq, R; Legrand, P; Lemire, A; Mérens, A; Miara, A; Moubareck, C; Muller-Serieys, C; Reverdy, ME; Roussel-Delvallez, M; Soussy, CJ	1
Nordmann, P	1
Kuijper, EJ; van Dissel, JT	1
Walsh, TR	1
Gomersall, C; Kuti, JL; Kwa, A; Montakantikul, P; Nicolau, DP; Roberts, JA	1
Goulenok, TM; Majed, K; Monchi, M	1
Hassan, A; Kaleem, F; Khan, A; Usman, J	1
Garg, A; Vashishtha, VM	1
Flamm, RK; Korten, V; Laeuffer, JM; Morrissey, I; Mutters, R; Nordmann, P; Picazo, JJ; Quintana, A; Seak, JC	1
Bassetti, M; Ginocchio, F; Mikulska, M	1
Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM	1
Gray, JW; Patel, M	1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN	1
Beloborodov, VB; Gruver, KP; Kuz'menko, TN	1
Bassetti, M; Giacobbe, DR; Ginocchio, F; Mikulska, M; Taramasso, L	1
Balderson, BJ; Patil, NP; Suda, KJ; Yates, ME	1
Livermore, DM; Nordmann, P; Poirel, L; Walsh, TR	1
Bharadwaj, R; Dohe, V; Gaikwad, V; Joshi, S; Kulkarni, G; Shouche, Y	1
Farbman, L; Leibovici, L; Paul, M; Yahav, D	1
Abandeh, FI; Drew, ME; Sopirala, MM	1
Badal, RE; Boffard, KD; Botha, RF; Brink, AJ; Feldman, C; Grolman, DC; Joubert, I; Poswa, X; Pretorius, J; Richards, GA; Senekal, M; Veller, M	1
Bille, E; Carbonnelle, E; Cattoir, V; Corvec, S; Fihman, V; Illiaquer, M; Jacquier, H; Jaureguy, F; Le Monnier, A; Tankovic, J; Zahar, JR	2
Borra, PS; El Salabi, A; Samuelsen, Ø; Toleman, MA; Walsh, TR	1
Baris, H; Cakir, N; Celen, M; Kurt, H; Laeuffer, J; Leblebicioglu, H	1
Babu, E; Bäcker, M; Bratu, S; Kelly, P; Landman, D; Olawole, O; Quale, J; Shah, N	1
Chongthaleong, A; Davies, T; Garcia, J; Kiratisin, P; Lagamayo, E; Roberts, S; Tan, TY	1
Boyd, DA; Bryce, E; Embree, J; Gravel, D; Katz, K; Kibsey, P; Kuhn, M; Mataseje, LF; Mounchili, A; Mulvey, MR; Roscoe, D; Simor, A; Taylor, G; Thomas, E; Turgeon, N	1
Cleveland, KO; Gelfand, MS	1
Akova, M; Carmeli, Y; Daikos, GL; Tzouvelekis, L	1
Han, L; He, X; Huang, L; Li, X; Liu, D; Liu, F; Liu, W; Shao, C; Wang, J; Wang, S; Wang, X; Wang, Y; Wei, X; Yang, Z; Yin, Z; Yuan, J; Zhu, L; Zou, D	1
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW	1
Esterly, JS; McLaughlin, MM; Postelnick, MJ; Qi, C; Scheetz, MH; Wagner, J	1
Dahle, UR; Samuelsen, Ø; Sundsfjord, A; Wester, AL	1
Aeinlang, N; Jaruratanasirikul, S; Jullangkoon, M; Kositpantawong, N; Wongpoowarak, W	1
Amoureux, L; Bador, J; Blanc, E; Neuwirth, C	1
Keel, RA; Kiratisin, P; Nicolau, DP	1
Blackburn, J; Bourgault, AM; Domingo, MC; Gilbert, A; Grenier, S; Lavergne, V; Lefebvre, B; Pilotte, J; Tremblay, C; Tsimiklis, C	1
Eguchi, K; Eriguchi, Y; Fujimoto, K; Hatano, K; Kanazawa, K; Matsumoto, M; Nakai, T; Sato, K; Shimizudani, T; Sunagawa, M; Takemoto, K; Terashita, S; Ueda, Y	1
Rajdev, S; Shivaprakasha, S; Singh, H; Velivala, S	1
Daikos, G; Katerelos, P; Kontopidou, F; Maltezou, HC; Roilides, E; Theodoridou, M	1
Johnson, AP; Woodford, N	1
Patterson, JE	2
Akiyama, K; Hiramatsu, N; Igari, J; Koyama, T; Oguri, T	1
Héritier, C; Nordmann, P; Poirel, L	1
Huang, ST; Ko, WC; Lee, HC; Lee, NY; Liu, KH; Yan, JJ	1
Abe, T; Fukuoka, T; Hirota, T; Inoue, H; Kakuta, M; Kitayama, A; Koga, T; Kuwahara, S; Masuda, N; Matsushita, Y; Nakagawa, M; Ohya, S; Shibayama, T; Sugihara, C; Takenouchi, T; Utsui, Y; Yoshida, T	1
Brahmadathan, KN; Gladstone, P; Rajendran, P	1
Avlamis, A; Katsandri, A; Legakis, NJ; Pantazatou, A; Papaparaskevas, J	1
Kizirgil, A; Toraman, ZA; Yakupogullari, Y	1
Eguchi, K; Eriguchi, Y; Kanazawa, K; Sunagawa, M; Takemoto, K; Ueda, Y	1
Rossolini, GM	1
Bell, JM; Franklin, C; Peleg, AY; Spelman, DW	1
Chen, WH; Hsueh, PR; Luh, KT	1
Chayakulkeeree, M; Junsriwong, P; Keerasuntonpong, A; Thamlikitkul, V; Tribuddharat, C	1
Eta, S; Kawahara, M	1
Iredell, JR; Sintchenko, V	1
Paterson, DL	1
Benjamin, DK; Cotten, CM; Goldberg, RN; McDonald, S; Poole, K; Stoll, B	1
Franklin, C; Liolios, L; Peleg, AY	1
Daschner, FD; Gastmeier, P; Jonas, D; Meyer, E; Rueden, H; Schwab, F	1
Bernander, S; Ericson, E; Fraenkel, CJ; Larsson, P; Melhus, A; Rydberg, J; Törnqvist, E; Ullberg, M	1
Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P	1
Alp, E; Aygen, B; Metan, G; Sumerkan, B	1
Fraser, VJ; Fridkin, SK; Kollef, MH; Merz, LR; Warren, DK	1
Aisenberg, G; Dickey, BF; Kontoyiannis, DP; Raad, II; Rolston, KV; Safdar, A	1
Espedido, B; Iredell, J; Thomas, L	1
Araujo, VR; Carvalho-Dias, VM; Cunha, CA; de Souza, CA; de Souza, M; Godoy, C; Lotfi, CJ; Maiolino, A; Nucci, M; Oliveira, AL; Pasquini, R; Ruiz, MA; Seber, A; Silla, L; Simões, BP; Tanaka, PY; Trabasso, P; Urakawa, P; Zanichelli, MA	1
Coratza, G; Docquier, JD; Mantengoli, E; Musmanno, RA; Rossolini, GM	1
Abraham, OC; Brahmadathan, KN; Jagannati, M; John, G; Kaul, S; Pitchamuthu, K; Sudarsanam, TD	1
Nordmann, P; Pitout, JD; Poirel, L	1
Cherkashin, EA; Galeeva, EV; Ivanov, DV; Krapivina, IV; Sidorenko, SV; Veshutova, NS	1
Deptuła, A; Gierlotka, K; Gospodarek, E; Michalska, A	1
Shah, PM	1
Kuti, JL; Nicasio, AM; Nicolau, DP	1
Jayashree, M; Mathew, JL; Ray, P; Singhi, S	1
Falagas, ME; Vergidis, PI	1
Ramphal, R	1
Owens, RC	1
Arakawa, Y; Ichiyama, S; Ito, H; Kato, N; Nakashima, K; Ohsuka, S; Ohta, M; Senda, K; Shimokata, K	1
Domon, H; Furuya, N; Ishii, K; Matsumoto, T; Miyazaki, S; Ohno, A; Tateda, K; Yamaguchi, K	1
Mokaddas, EM; Sanyal, SC	1
Kuwabara, K; Wada, K	1
Biedenbach, DJ; Jones, RN; Kugler, KC	1
Allerberger, F; Reisinger, EC	1
Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K	1
Forward, KR; Gales, AC; Jones, RN; Liñares, J; Sader, HS; Verhoef, J	1
Dascal, A; Miller, MA; Zaharatos, GJ	1
Akova, M; Gür, D; Kocagöz, S; Köseoğlu , O	1

Reviews

104 review(s) available for carbapenems and Bacterial Infections, Gram-Negative

Article	Year
Cefiderocol: A New Cephalosporin Stratagem Against Multidrug-Resistant Gram-Negative Bacteria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 04-09, Volume: 74, Issue:7 Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2022
Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions. Archives of medical research, 2021, Volume: 52, Issue:8 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Sepsis	2021
Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections. Expert opinion on drug safety, 2022, Volume: 21, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxins	2022
New antibiotics for the treatment of nonfermenting Gram-negative bacteria. Current opinion in infectious diseases, 2021, 12-01, Volume: 34, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2021
The role of Gram-negative bacteria in skin and soft tissue infections. Current opinion in infectious diseases, 2022, 04-01, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Soft Tissue Infections	2022
Cefiderocol: A new Antimicrobial for Complicated Urinary Tract Infection (CUTI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE). Current drug research reviews, 2022, Volume: 14, Issue:1 Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Siderophores; Urinary Tract Infections	2022
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Communicable Diseases; Critical Care; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2022
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies. Expert review of anti-infective therapy, 2022, Volume: 20, Issue:5 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prospective Studies	2022
Efficacy and Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Tazobactam	2022
Update of clinical application in ceftazidime-avibactam for multidrug-resistant Gram-negative bacteria infections. Infection, 2022, Volume: 50, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2022
Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections. International journal of antimicrobial agents, 2022, Volume: 60, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2022
A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35, Issue:5 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Consensus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia; Respiratory System; Risk Factors	2022
New antimicrobial treatment options for severe Gram-negative infections. Current opinion in critical care, 2022, 10-01, Volume: 28, Issue:5 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2022
Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 2 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Tetracyclines	2022
The role of cefiderocol in clinical practice. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2022, Volume: 35 Suppl 2 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2022
Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics. Infectious disease clinics of North America, 2022, Volume: 36, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests	2022
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic? Current opinion in infectious diseases, 2022, 12-01, Volume: 35, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; COVID-19; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pandemics	2022
ESCMID/EUCIC clinical practice guidelines on perioperative antibiotic prophylaxis in patients colonized by multidrug-resistant Gram-negative bacteria before surgery. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:4 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Monobactams; Prospective Studies	2023
Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. The Lancet. Infectious diseases, 2023, Volume: 23, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Regression Analysis; Vancomycin-Resistant Enterococci	2023
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Expert review of anti-infective therapy, 2023, Volume: 21, Issue:4 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxin B; Polymyxins; Retrospective Studies; Rifampin	2023
Treatment options for multidrug-resistant Gram-negatives in urinary tract infections. Current opinion in urology, 2023, 05-01, Volume: 33, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Gram-Negative Bacterial Infections; Humans; Imipenem; Urinary Tract Infections	2023
Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2023, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control	2023
Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trials. Journal of global antimicrobial resistance, 2023, Volume: 34 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Intraabdominal Infections; Network Meta-Analysis; Randomized Controlled Trials as Topic; Urinary Tract Infections	2023
Treatment of Resistant Gram-negative bacilli in children. Infectious diseases now, 2023, Volume: 53, Issue:8S Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2023
Efficacy of ceftazidime/avibactam in monotherapy or combination therapy against carbapenem-resistant Gram-negative bacteria: A meta-analysis. International journal of antimicrobial agents, 2019, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2019
Modifiable risk factors for multidrug-resistant Gram-negative infection in critically ill burn patients: a systematic review and meta-analysis. ANZ journal of surgery, 2019, Volume: 89, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Burns; Carbapenems; Cephalosporins; Critical Illness; Cross Infection; Drug Resistance, Multiple; Gram-Negative Bacterial Infections; Humans; Hydrotherapy; Intensive Care Units; Penicillins; Respiration, Artificial; Risk Factors; Urinary Catheters; Vascular Access Devices	2019
Epidemiology of carbapenem-resistant Gram-negative infections globally. Current opinion in infectious diseases, 2019, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; Carbapenems; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Prevalence; Public Health Surveillance	2019
Risk stratification for multidrug-resistant Gram-negative infections in ICU patients. Current opinion in infectious diseases, 2019, Volume: 32, Issue:6 Topics: beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Mass Screening; Prognosis; Risk Assessment; Risk Factors	2019
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-13, Volume: 69, Issue:Suppl 7 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Clinical Trials as Topic; Drug Resistance, Bacterial; Forecasting; Gram-Negative Bacterial Infections; Humans; Public Health	2019
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 11-13, Volume: 69, Issue:Suppl 7 Topics: Carbapenems; Drug Resistance, Bacterial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2019
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia. Current opinion in infectious diseases, 2020, Volume: 33, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftriaxone; Cephalosporin Resistance; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Randomized Controlled Trials as Topic	2020
Carbapenem-Resistant Gram-Negative Bacterial Infections in Children. Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans	2020
Neonatal Sepsis: Treatment of Neonatal Sepsis in Multidrug-Resistant (MDR) Infections: Part 2. Indian journal of pediatrics, 2020, Volume: 87, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; Blood Culture; Carbapenems; Colistin; Drug Resistance, Multiple; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Klebsiella; Neonatal Sepsis	2020
Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Renal Replacement Therapy	2020
Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis. BMC infectious diseases, 2020, Jun-11, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Treatment Outcome	2020
Antimicrobial agents and chemotherapy, 2020, 10-20, Volume: 64, Issue:11 Topics: Achromobacter; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2020
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection, 2020, Volume: 48, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Klebsiella Infections; Klebsiella pneumoniae; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline	2020
Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Genotyping Techniques; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2020
The role of new antimicrobials for Gram-negative infections in daily clinical practice. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines	2020
Is it time to move away from polymyxins?: evidence and alternatives. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Developing Countries; Drug Resistance, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxins	2021
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:2 Topics: Carbapenems; Case-Control Studies; Cross Infection; Dialysis; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Prospective Studies; Respiration, Artificial; Retrospective Studies; Risk Factors	2021
Burden of carbapenem non-susceptible infections in high-risk patients: systematic literature review and meta-analysis. Antimicrobial resistance and infection control, 2020, 12-07, Volume: 9, Issue:1 Topics: Aged; Carbapenems; Cost of Illness; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Length of Stay; Male; Middle Aged	2020
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International journal of antimicrobial agents, 2021, Volume: 57, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin	2021
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies. BMC infectious diseases, 2021, Jun-09, Volume: 21, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Clinical Studies as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa	2021
Risk factors for, and molecular epidemiology and clinical outcomes of, carbapenem- and polymyxin-resistant Gram-negative bacterial infections in pregnant women, infants, and toddlers: a systematic review and meta-analyses. Annals of the New York Academy of Sciences, 2021, Volume: 1502, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Middle Aged; Molecular Epidemiology; Mortality; Polymyxins; Pregnancy; Pregnancy Complications, Infectious; Risk Assessment; Risk Factors; Young Adult	2021
Sparing carbapenem usage. The Journal of antimicrobial chemotherapy, 2017, 09-01, Volume: 72, Issue:9 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Utilization; Formularies, Hospital as Topic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2017
Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms. Journal of clinical microbiology, 2018, Volume: 56, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Clinical Decision-Making; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination	2018
Epidemiology and treatment of antimicrobialresistant gram-negative bacteria in Korea. The Korean journal of internal medicine, 2018, Volume: 33, Issue:2 Topics: Acinetobacter baumannii; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Republic of Korea; Retrospective Studies	2018
Evaluation of the efficacy and safety of ceftazidime/avibactam in the treatment of Gram-negative bacterial infections: a systematic review and meta-analysis. International journal of antimicrobial agents, 2018, Volume: 52, Issue:4 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Patient Safety; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Urinary Tract Infections	2018
Tebipenem, the first oral carbapenem antibiotic. Expert review of anti-infective therapy, 2018, Volume: 16, Issue:7 Topics: Administration, Oral; Adult; Animals; Anti-Bacterial Agents; Carbapenems; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prodrugs	2018
Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens. Expert opinion on drug metabolism & toxicology, 2019, Volume: 15, Issue:2 Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2019
The role of carbapenem-resistant pathogens in cSSTI and how to manage them. Current opinion in infectious diseases, 2019, Volume: 32, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Diagnostic Tests, Routine; Disease Management; Drug Therapy; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Skin Diseases, Bacterial; Soft Tissue Infections	2019
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Drugs, 2019, Volume: 79, Issue:3 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Molecular Structure; Randomized Controlled Trials as Topic; Siderophores	2019
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial Infections. Drugs, 2019, Volume: 79, Issue:3 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Clinical Trials as Topic; Colistin; Dose-Response Relationship, Drug; Drug Approval; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Randomized Controlled Trials as Topic; Sisomicin; United States; United States Food and Drug Administration; Urinary Tract Infections	2019
Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms. Journal of the Pediatric Infectious Diseases Society, 2019, Jul-01, Volume: 8, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Boronic Acids; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Meropenem; Tazobactam	2019
Reversing resistance to counter antimicrobial resistance in the World Health Organisation's critical priority of most dangerous pathogens. Bioscience reports, 2019, 04-30, Volume: 39, Issue:4 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Drug Discovery; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Permeability; World Health Organization	2019
Meta-analysis of Polymyxin Use in Patients. Advances in experimental medicine and biology, 2019, Volume: 1145 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Polymyxins; Randomized Controlled Trials as Topic; Retrospective Studies	2019
Ertapenem use and antimicrobial resistance to group 2 carbapenems in Gram-negative infections: a systematic review. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pseudomonas aeruginosa	2013
β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula. Clinical microbiology reviews, 2013, Volume: 26, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Middle East; Public Health Surveillance	2013
Combination therapy for Gram-negative bacteria: what is the evidence? Expert review of anti-infective therapy, 2013, Volume: 11, Issue:12 Topics: Anti-Bacterial Agents; Carbapenems; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination	2013
Combination therapy for carbapenem-resistant Gram-negative bacteria. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline	2013
Treatment of multidrug-resistant Gram-negative infections in children. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Volume: 58, Issue:10 Topics: Acinetobacter baumannii; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2014
Combination therapy for carbapenem-resistant Gram-negative bacteria. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Randomized Controlled Trials as Topic; Treatment Outcome	2014
Antibiotic-resistant gram-negative bacterial infections in patients with cancer. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Nov-15, Volume: 59 Suppl 5 Topics: Acinetobacter baumannii; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Neoplasms; Pseudomonas aeruginosa; Stenotrophomonas maltophilia	2014
Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician. Mayo Clinic proceedings, 2015, Volume: 90, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Infection Control	2015
Treatment of MDR-Gram negative infections in the 21st century: a never ending threat for clinicians. Current opinion in pharmacology, 2015, Volume: 24 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans	2015
Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond. The Urologic clinics of North America, 2015, Volume: 42, Issue:4 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Pseudomonas aeruginosa; Risk Factors	2015
Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management. Pharmacotherapy, 2015, Volume: 35, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Risk Factors; United States	2015
Carbapenem susceptibility breakpoints, clinical implications with the moving target. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2016
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:3 Topics: Acinetobacter; Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Drug Resistance, Bacterial; Female; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Israel; Italy; Klebsiella; Klebsiella Infections; Male; Middle Aged; Neutropenia; Prevalence; Pseudomonas	2017
[Broad-spectrum beta-lactamases in Gram-negative bacteria]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008, Dec-04, Volume: 128, Issue:23 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Monobactams; Penicillins; Plasmids	2008
Doripenem: position in clinical practice. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections	2009
Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs, 2009, Oct-01, Volume: 69, Issue:14 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline	2009
Carbapenemases: a brief review for pediatric infectious disease specialists. The Pediatric infectious disease journal, 2010, Volume: 29, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2010
Newer antibacterial drugs for a new century. Expert opinion on investigational drugs, 2010, Volume: 19, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Delivery Systems; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Drugs, Investigational; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Macrolides; Minocycline; Oxazolidinones; Tigecycline	2010
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Policy; Humans; Infection Control	2010
[Pediatric use of carbapenems]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2010, Volume: 17 Suppl 4 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Child; Drug Tolerance; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Thienamycins	2010
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitals, Teaching; Humans; Microbial Sensitivity Tests	2011
[Gram-negative bacteriae with resistance to carbapenems]. Medecine sciences : M/S, 2010, Volume: 26, Issue:11 Topics: beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Oxacillin	2010
[The rise of resistant gram-negative bacteria]. Nederlands tijdschrift voor geneeskunde, 2010, Volume: 154, Issue:45 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Food Chain; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Veterinary Medicine	2010
Emerging carbapenemases: a global perspective. International journal of antimicrobial agents, 2010, Volume: 36 Suppl 3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prevalence	2010
Role and impact of carbapenem in nosocomial infections. Recent patents on anti-infective drug discovery, 2011, Volume: 6, Issue:1 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cross Infection; Dosage Forms; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Patents as Topic	2011
New treatment options against gram-negative organisms. Critical care (London, England), 2011, Volume: 15, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Drug Resistance, Multiple; Drugs, Investigational; Gram-Negative Bacterial Infections; Humans; United States	2011
Management of antibiotic-resistant infection in the newborn. Archives of disease in childhood. Education and practice edition, 2011, Volume: 96, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Carbapenems; Colistin; Daptomycin; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Linezolid; Oxazolidinones; Vancomycin	2011
Will new antimicrobials overcome resistance among Gram-negatives? Expert review of anti-infective therapy, 2011, Volume: 9, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactamases; Carbapenems; Clinical Trials as Topic; Drug Administration Schedule; Drug Discovery; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Indoles; Infection Control; Microbial Sensitivity Tests; Monobactams; Polymyxins; Protein Synthesis Inhibitors	2011
The emerging NDM carbapenemases. Trends in microbiology, 2011, Volume: 19, Issue:12 Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; Enterobacteriaceae; Gene Transfer, Horizontal; Gram-Negative Bacterial Infections; Humans; Plasmids; Pseudomonas; Vibrionaceae	2011
Colistin: new lessons on an old antibiotic. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Clinical Trials as Topic; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2012
Carbapenem-hydrolyzing gram-negative bacteria: current options for treatment and review of drugs in development. Recent patents on anti-infective drug discovery, 2012, Volume: 7, Issue:1 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Discovery; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis	2012
Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Risk Factors	2012
Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 4 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gene Transfer, Horizontal; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Plasmids	2013
Extended spectrum beta-lactamases: a therapeutic dilemma. The Pediatric infectious disease journal, 2002, Volume: 21, Issue:10 Topics: Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome	2002
Resistance in gram-negative bacteria: enterobacteriaceae. The American journal of medicine, 2006, Volume: 119, Issue:6 Suppl 1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections	2006
Beta-lactam resistance in the gram negatives: increasing complexity of conditional, composite and multiply resistant phenotypes. Pathology, 2006, Volume: 38, Issue:6 Topics: Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Phenotype; Terminology as Topic	2006
Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains. The new microbiologica, 2007, Volume: 30, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Europe; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; North America	2007
Carbapenemases: molecular diversity and clinical consequences. Future microbiology, 2007, Volume: 2, Issue:5 Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2007
Parenteral carbapenems. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14 Suppl 1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Parenteral; Meropenem; Thienamycins	2008
The current state of multidrug-resistant gram-negative bacilli in North America. Pharmacotherapy, 2008, Volume: 28, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; North America; Polymyxins; Sulbactam; Tigecycline	2008
Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options. Current opinion in investigational drugs (London, England : 2000), 2008, Volume: 9, Issue:2 Topics: Animals; Carbapenems; Cephalosporins; Clinical Trials as Topic; Drug Resistance, Multiple, Bacterial; Glycylglycine; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxins	2008
Doripenem: an expected arrival in the treatment of infections caused by multidrug-resistant Gram-negative pathogens. Expert opinion on investigational drugs, 2008, Volume: 17, Issue:5 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Clinical Trials, Phase III as Topic; Doripenem; Drug Evaluation; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Structure	2008
An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in? Critical care (London, England), 2008, Volume: 12 Suppl 4 Topics: Carbapenems; Central Nervous System Diseases; Clostridioides difficile; Clostridium Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Glucose Metabolism Disorders; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heart Diseases; Humans	2008
The role of carbapenems in initial therapy for serious Gram-negative infections. Critical care (London, England), 2008, Volume: 12 Suppl 4 Topics: Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2008
[Metallo-beta-lactamase producing gram negative rods infection]. Ryoikibetsu shokogun shirizu, 1999, Issue:23 Pt 1 Topics: beta-Lactamases; Carbapenems; Diagnosis, Differential; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Bacterial Infections; Humans	1999
Extended-spectrum beta-lactamases. Seminars in respiratory infections, 2000, Volume: 15, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Intensive Care Units; Prevalence; R Factors; Risk Factors	2000

Trials

10 trial(s) available for carbapenems and Bacterial Infections, Gram-Negative

Article	Year
Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:12 Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans	2020
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:9 Topics: Aged; Aged, 80 and over; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2020
Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2 Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea	2022
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. The Lancet. Infectious diseases, 2021, Volume: 21, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult	2021
The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:12 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Treatment Outcome	2018
Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive ca BMJ open, 2019, 02-19, Volume: 9, Issue:2 Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Deprescriptions; Enterobacteriaceae Infections; Equivalence Trials as Topic; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Mortality; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections	2019
Impact of Preemptive Granulocyte Infusions During Febrile Neutropenia in Patients Colonized with Carbapenem-Resistant Gram-Negative Bacteria Undergoing Haploidentical Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:8 Topics: Adolescent; Adult; Aged; Allografts; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Disease-Free Survival; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Granulocytes; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Leukocyte Transfusion; Male; Middle Aged; Prospective Studies; Survival Rate; Time Factors	2019
Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study. Clinical therapeutics, 2008, Volume: 30, Issue:5 Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins	2008
Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia. International journal of antimicrobial agents, 2012, Volume: 40, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors	2012
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis	2006

Other Studies

275 other study(ies) available for carbapenems and Bacterial Infections, Gram-Negative

Article	Year
Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India. PloS one, 2021, Volume: 16, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clinical Laboratory Services; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Young Adult	2021
Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections. BMC infectious diseases, 2021, Oct-04, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxin B; Retrospective Studies	2021
Using Molecular Diagnostics to Develop Therapeutic Strategies for Carbapenem-Resistant Gram-Negative Infections. Frontiers in cellular and infection microbiology, 2021, Volume: 11 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Pathology, Molecular	2021
Clinical management of cUTI, cIAI, and HABP/VABP attributable to carbapenem-resistant Gram-negative infections in Spain. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34, Issue:6 Topics: Aftercare; Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Patient Discharge; Pneumonia, Bacterial; Retrospective Studies; Spain; Urinary Tract Infections; Ventilators, Mechanical	2021
A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections. Scientific reports, 2021, 12-06, Volume: 11, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cytokines; Drug Design; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Gram-Negative Bacterial Infections; Humans; Inflammation; Klebsiella pneumoniae; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Phagocytosis; Sepsis	2021
Environmental spreading of clinically relevant carbapenem-resistant gram-negative bacilli: the occurrence of bla BMC microbiology, 2022, 01-04, Volume: 22, Issue:1 Topics: Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Catchment Area, Health; Drug Resistance, Bacterial; Environmental Monitoring; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Hospitals, District; Humans; Sewage; Water Microbiology; Water Purification	2022
Prevalence and characterization of antimicrobial resistance among gram-negative bacteria isolated from febrile hospitalized patients in central Ethiopia. Antimicrobial resistance and infection control, 2022, 01-15, Volume: 11, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Ethiopia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Middle Aged; Prevalence; Young Adult	2022
Acquisition of carbapenem-resistant gram-negative bacilli among intensive care unit (ICU) patients with no previous use of carbapenems: Indirect population impact of antimicrobial use. Infection control and hospital epidemiology, 2022, Volume: 43, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units	2022
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective. Expert review of anti-infective therapy, 2022, Volume: 20, Issue:7 Topics: Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Ventilator-Associated	2022
A Longitudinal Study of Spontaneous Gut Decolonization of Carbapenem-resistant Gram-negative Bacteria in Neonatal and Pediatric Patients. The Pediatric infectious disease journal, 2022, 08-01, Volume: 41, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Longitudinal Studies; Retrospective Studies	2022
Genome-wide identification of carbapenem-resistant Gram-negative bacterial (CR-GNB) isolates retrieved from hospitalized patients in Bihar, India. Scientific reports, 2022, 05-19, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Escherichia coli; Gram-Negative Bacterial Infections; Humans; India; Klebsiella pneumoniae; Microbial Sensitivity Tests	2022
Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK). Advances in therapy, 2022, Volume: 39, Issue:8 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; United Kingdom	2022
Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study. Antimicrobial resistance and infection control, 2022, 06-22, Volume: 11, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Watchful Waiting	2022
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB. Blood advances, 2023, 05-09, Volume: 7, Issue:9 Topics: Anti-Infective Agents; Carbapenems; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Neutropenia; Piperacillin; Retrospective Studies; Tazobactam; Transplantation, Homologous	2023
Investigation and analysis of carbapenem-resistant gram-negative bacterial infection rates across hospitals in Shandong Province in China. Frontiers in public health, 2022, Volume: 10 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans	2022
Use of hospital resources in ICU inpatients with infections caused by carbapenem-resistant Gram-negative bacteria: A real clinical practice-based study in Spain. Enfermedades infecciosas y microbiologia clinica (English ed.), 2023, Volume: 41, Issue:3 Topics: Aged; Anti-Bacterial Agents; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Inpatients; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Spain	2023
A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria. The Journal of antimicrobial chemotherapy, 2023, 04-03, Volume: 78, Issue:4 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; COVID-19; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Pandemics	2023
Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development. Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Retrospective Studies	2023
Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections. The Pediatric infectious disease journal, 2023, 05-01, Volume: 42, Issue:5 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Gram-Negative Bacterial Infections; Humans; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sepsis; Stenotrophomonas maltophilia	2023
Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products. The Journal of biological chemistry, 2023, Volume: 299, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Crystallography; Gram-Negative Bacterial Infections; Humans; Kinetics; Stenotrophomonas maltophilia	2023
Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria. International journal of antimicrobial agents, 2023, Volume: 62, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Salvage Therapy	2023
Modifiable risk factors associated with later gut decolonization of carbapenem-resistant Gram-negative bacteria in children: a prospective cohort study. The Journal of hospital infection, 2023, Volume: 136 Topics: Anti-Bacterial Agents; Carbapenems; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prospective Studies; Risk Factors	2023
Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study. Journal of infection and public health, 2023, Volume: 16, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Ceftazidime; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Microbial Sensitivity Tests; Retrospective Studies	2023
Active screening and patient-placement and cohort-placement strategies to decrease carbapenem-resistant gram-negative bacilli colonization and infection in pediatric patients: A 5-year retrospective observational study in China. Infection control and hospital epidemiology, 2023, Volume: 44, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Child; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Retrospective Studies	2023
Risk factors of carbapenem-resistant gram-negative bacteria pneumonia and mortality. Cellular and molecular biology (Noisy-le-Grand, France), 2022, Sep-30, Volume: 68, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Pneumonia, Bacterial; Retrospective Studies; Risk Factors	2022
Risk of relapse and readmission among hospitalized adults with carbapenem non-susceptible gram-negative infections. Current medical research and opinion, 2023, Volume: 39, Issue:6 Topics: Adult; Aftercare; Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacterial Infections; Humans; Patient Discharge; Patient Readmission; Retrospective Studies; Urinary Tract Infections	2023
Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB. BMC infectious diseases, 2023, May-25, Volume: 23, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxin B; Polymyxins; Retrospective Studies	2023
Real-world effectiveness of ceftazidime/avibactam versus polymyxin B in treating patients with carbapenem-resistant Gram-negative bacterial infections. International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxin B; Retrospective Studies	2023
Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Long-Term Care; Prevalence; Risk Factors	2023
High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 07-05, Volume: 77, Issue:Suppl 1 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Chile; COVID-19; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Risk Factors	2023
Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 07-05, Volume: 77, Issue:Suppl 1 Topics: Anti-Bacterial Agents; Carbapenems; COVID-19; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxins; Retrospective Studies; Sepsis	2023
Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study. Annals of clinical microbiology and antimicrobials, 2023, Aug-03, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Child; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Risk Factors; Tertiary Care Centers	2023
Impact of carbapenem-targeted antimicrobial stewardship interventions: an interrupted time-series analysis. The Journal of hospital infection, 2023, Volume: 140 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2023
Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study. The American journal of tropical medicine and hygiene, 2023, 11-01, Volume: 109, Issue:5 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Peru; Prevalence; Pseudomonas aeruginosa; Sepsis	2023
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience. The Journal of antimicrobial chemotherapy, 2023, 11-06, Volume: 78, Issue:11 Topics: Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies	2023
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 10-16, Volume: 77, Issue:Suppl 4 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Leadership; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2023
Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2019, Volume: 24, Issue:33 Topics: Acinetobacter; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Europe; European Union; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sentinel Surveillance	2019
Characterisation of carbapenem-resistant Gram-negative organisms from clinical specimens in Yola, Nigeria. Journal of global antimicrobial resistance, 2020, Volume: 21 Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Nigeria	2020
Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PloS one, 2019, Volume: 14, Issue:9 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Ethiopia; Fermentation; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prevalence; Prospective Studies	2019
Evaluation of the Direct MacConkey Method for Identification of Carbapenem-Resistant Gram-Negative Organisms from Rectal Swabs: Reevaluating Zone Diameter Cutoffs. Journal of clinical microbiology, 2019, Volume: 57, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disk Diffusion Antimicrobial Tests; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem; Rectum; ROC Curve; Sensitivity and Specificity	2019
Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Klebsiella pneumoniae; Liver Transplantation; Male; Retrospective Studies; Tigecycline; Treatment Outcome	2020
Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients. Antimicrobial resistance and infection control, 2019, Volume: 8 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Male; Middle Aged; Prevalence; Public Health Surveillance; Transplant Recipients	2019
Risk factors for development of aminoglycoside resistance among gram-negative rods. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019, 10-30, Volume: 76, Issue:22 Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Algorithms; Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Patient Transfer; Respiration, Artificial; Retrospective Studies; Risk Factors; Sex Factors; Weight Loss; Young Adult	2019
Mortality risk of bloodstream infection caused by either Escherichia coli or Klebsiella pneumoniae producing extended-spectrum β-lactamase: a prospective cohort study. BMC research notes, 2019, Nov-01, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Bacteremia; beta-Lactamases; Carbapenems; Child; Child, Preschool; Escherichia coli; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Risk Factors; Survival Rate	2019
Quercetin inhibits carbapenemase and efflux pump activities among carbapenem-resistant Gram-negative bacteria. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2020, Volume: 128, Issue:3 Topics: Amino Acids; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Molecular Docking Simulation; Quercetin	2020
Risk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteria. Le infezioni in medicina, 2019, Dec-01, Volume: 27, Issue:4 Topics: Acute Kidney Injury; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors	2019
Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:5 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Predictive Value of Tests; Prevalence; Retrospective Studies; Risk Factors	2020
The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 93 Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Meropenem; Middle Aged; Organ Dysfunction Scores; Philippines; Respiratory Tract Infections; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult	2020
Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance Data. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 12-03, Volume: 71, Issue:9 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies	2020
Drivers of press media response to healthcare-associated infections caused by multidrug-resistant organisms: A report from Brazil. Infection control and hospital epidemiology, 2020, Volume: 41, Issue:3 Topics: Acinetobacter baumannii; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacterial Infections; Health Policy; Humans; Mass Media	2020
Characteristics of Stenotrophomonas maltophilia infection in children in Sichuan, China, from 2010 to 2017. Medicine, 2020, Volume: 99, Issue:8 Topics: Age Distribution; Anti-Bacterial Agents; Carbapenems; Ceftazidime; Child, Preschool; China; Clavulanic Acids; Comorbidity; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Immunosuppressive Agents; Infant; Intensive Care Units, Pediatric; Length of Stay; Male; Piperacillin, Tazobactam Drug Combination; Respiration, Artificial; Retrospective Studies; Risk Factors; Sex Distribution; Stenotrophomonas maltophilia; Surgical Procedures, Operative; Ticarcillin; Trimethoprim, Sulfamethoxazole Drug Combination	2020
In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units. Diagnostic microbiology and infectious disease, 2020, Volume: 97, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Canada; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Siderophores; Stenotrophomonas maltophilia	2020
Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections. PloS one, 2020, Volume: 15, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Care Costs; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prognosis; Respiratory Tract Infections; Retrospective Studies; Survival Rate; Young Adult	2020
Association between the rate of fluoroquinolones-resistant gram-negative bacteria and antibiotic consumption from China based on 145 tertiary hospitals data in 2014. BMC infectious diseases, 2020, Apr-07, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Utilization; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillins; Retrospective Studies; Tertiary Care Centers	2020
Opportunities for antimicrobial stewardship among carbapenem-treated patients in 18 North American hospitals. International journal of antimicrobial agents, 2020, Volume: 55, Issue:6 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cross-Sectional Studies; Drug Utilization; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Impatiens; Male; Middle Aged; North America; Retrospective Studies; Treatment Outcome	2020
Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia. BMC infectious diseases, 2020, Jun-09, Volume: 20, Issue:1 Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Tertiary Care Centers; Treatment Outcome	2020
A highly multiplexed melt-curve assay for detecting the most prevalent carbapenemase, ESBL, and AmpC genes. Diagnostic microbiology and infectious disease, 2020, Volume: 97, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Molecular Diagnostic Techniques; Multiplex Polymerase Chain Reaction; Sensitivity and Specificity	2020
Shedding of multidrug-resistant gram-negative bacilli by colonized patients during procedures and patient care activities. American journal of infection control, 2020, Volume: 48, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Patient Care	2020
Evidence in Microbiome Science: Standards for the Field (and Laboratory). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 05-04, Volume: 72, Issue:9 Topics: Carbapenems; Gram-Negative Bacterial Infections; Humans; Laboratories; Leukemia, Myeloid, Acute; Microbiota; Stenotrophomonas maltophilia	2021
Alterations of the Oral Microbiome and Cumulative Carbapenem Exposure Are Associated With Stenotrophomonas maltophilia Infection in Patients With Acute Myeloid Leukemia Receiving Chemotherapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 05-04, Volume: 72, Issue:9 Topics: Carbapenems; Gram-Negative Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Microbiota; Prospective Studies; RNA, Ribosomal, 16S; Stenotrophomonas maltophilia	2021
Implementing carbapenem-resistance testing algorithms for Enterobacteriales and Pseudomonas aeruginosa: diagnostic and antimicrobial stewardship with timely infection prevention. Diagnostic microbiology and infectious disease, 2020, Volume: 97, Issue:4 Topics: Algorithms; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Clinical Laboratory Techniques; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Middle Aged; Pseudomonas aeruginosa	2020
Determining the burden of infectious diseases caused by carbapenem-resistant gram-negative bacteria in Spain. Enfermedades infecciosas y microbiologia clinica (English ed.), 2021, Volume: 39, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Communicable Diseases; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Spain	2021
Temporal association between carbapenems usage and antimicrobial resistance in gram-negative bacteria at a tertiary hospital in Nanjing, China. Diagnostic microbiology and infectious disease, 2020, Volume: 98, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Ceftazidime; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Utilization; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inpatients; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers	2020
The occurrence of Salmonella, extended-spectrum β-lactamase producing Escherichia coli and carbapenem resistant non-fermenting Gram-negative bacteria in a backyard poultry flock environment. Zoonoses and public health, 2020, Volume: 67, Issue:6 Topics: Aged; Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chickens; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Housing, Animal; Humans; Salmonella; Salmonella Infections, Animal; Surveys and Questionnaires	2020
Metagenomic next-generation sequencing of rectal swabs for the surveillance of antimicrobial-resistant organisms on the Illumina Miseq and Oxford MinION platforms. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:1 Topics: Carbapenems; Drug Resistance, Bacterial; Genome, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Metagenomics; Rectum; Vancomycin-Resistant Enterococci	2021
Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study. Antimicrobial resistance and infection control, 2020, 08-14, Volume: 9, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Sepsis; Tertiary Care Centers; Young Adult	2020
The stability of carbapenems before and after admixture to PMMA-cement used for replacement surgery caused by Gram-negative bacteria. European journal of medical research, 2020, Aug-18, Volume: 25, Issue:1 Topics: Anti-Bacterial Agents; Arthroplasty, Replacement; Austria; Bone Cements; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymethyl Methacrylate; Prosthesis-Related Infections	2020
Epidemiologic, Phenotypic, and Structural Characterization of Aminoglycoside-Resistance Gene International journal of molecular sciences, 2020, Aug-25, Volume: 21, Issue:17 Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Catalytic Domain; Databases, Genetic; Drug Resistance, Bacterial; Genome, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Methyltransferases; Molecular Epidemiology; Mutagenesis, Site-Directed; Nebramycin; Standard of Care; Structure-Activity Relationship	2020
Clinical efficacy and safety of novel carbapenem/β-lactamase inhibitor combinations against carbapenem-non-susceptible Gram-negative bacterial infection. Journal of global antimicrobial resistance, 2020, Volume: 23 Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenems; Gram-Negative Bacterial Infections; Humans; Treatment Outcome	2020
Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 12-06, Volume: 73, Issue:11 Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies	2021
Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram-negative Bloodstream Infections: "Every day matters". Pharmacotherapy, 2020, Volume: 40, Issue:9 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; New York; Patient Discharge; Retrospective Studies; Time-to-Treatment; Young Adult	2020
Evaluation of a polymyxin drop test for polymyxin resistance detection among non-fermentative gram-negative rods and enterobacterales resistant to carbapenems. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2021, Volume: 129, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymyxin B	2021
Multicenter Evaluation of Xpert Carba-R Assay for Detection and Identification of the Carbapenemase Genes in Rectal Swabs and Clinical Isolates. The Journal of molecular diagnostics : JMD, 2021, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Female; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Real-Time Polymerase Chain Reaction; Rectum; Reproducibility of Results; Sensitivity and Specificity	2021
Early identification and optimal management of carbapenem-resistant Gram-negative infection. The Journal of hospital infection, 2021, Volume: 108 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Consensus; Drug Resistance, Bacterial; France; Germany; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Infection Control; Italy; Spain; United Kingdom	2021
Healthcare resource use in hospitalized patients with carbapenem-resistant Gram-negative infections. The Journal of hospital infection, 2021, Volume: 110 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Delivery of Health Care; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Health Care Costs; Hospitalization; Humans; Inpatients; London; Retrospective Studies	2021
Nosocomial Non-fermentative gram negative bacteria bloodstream infections in children; Risk factors and clinical outcomes of carbapenem resistance. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:5 Topics: Anti-Bacterial Agents; Carbapenems; Child; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Risk Factors; Sepsis	2021
Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates. PloS one, 2021, Volume: 16, Issue:1 Topics: Adult; Aged; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Liver Cirrhosis; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prevalence; Prospective Studies; Retrospective Studies; Staphylococcal Infections; Tertiary Care Centers; Vancomycin-Resistant Enterococci	2021
Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Prognosis; Retrospective Studies; Risk Factors; Treatment Outcome	2021
Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome	2021
Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya. PloS one, 2021, Volume: 16, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Genes, Bacterial; Genes, MDR; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kenya	2021
Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021, Volume: 106 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pakistan; Prospective Studies; Treatment Outcome	2021
Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network. PloS one, 2021, Volume: 16, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Genes, Bacterial; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Mexico; Microbial Sensitivity Tests; Phenotype	2021
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia. International journal of antimicrobial agents, 2021, Volume: 57, Issue:6 Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Autografts; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Tazobactam; Treatment Outcome; Young Adult	2021
Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan. BMC microbiology, 2021, 05-04, Volume: 21, Issue:1 Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Sudan	2021
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cross-Sectional Studies; Developed Countries; Developing Countries; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2022
Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019. BMC infectious diseases, 2021, May-17, Volume: 21, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Burkholderia cepacia; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Linear Models; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers; Tetracyclines	2021
Characterization of carbapenem-resistant gram-negative bacterial isolates from Nigeria by whole genome sequencing. Diagnostic microbiology and infectious disease, 2021, Volume: 101, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Genome, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Nigeria	2021
Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimens. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Feces; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymerase Chain Reaction; Sensitivity and Specificity	2021
Stenotrophomonas maltophilia Susceptibility Testing Challenges and Strategies. Journal of clinical microbiology, 2021, 08-18, Volume: 59, Issue:9 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Stenotrophomonas maltophilia	2021
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals. The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cefiderocol; Ceftazidime; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inpatients; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Pseudomonas aeruginosa; Thienamycins; Tigecycline	2017
The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Carbapenems; Chi-Square Distribution; Drug Resistance, Multiple, Bacterial; Female; Germany; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sepsis; Time Factors; Treatment Outcome; Young Adult	2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii. Nature microbiology, 2017, Jun-30, Volume: 2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Dogs; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Mice; Models, Molecular; Penicillin-Binding Proteins; Rats; Sulbactam	2017
Current problematic and emergence of carbapenemase-producing bacteria: a brief report from a Libyan hospital. The Pan African medical journal, 2017, Volume: 26 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Libya; Microbial Sensitivity Tests	2017
Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Child; Child, Preschool; Drug Utilization; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Inappropriate Prescribing; Infant; Infant, Newborn; Middle Aged; Prescriptions; Retrospective Studies; Treatment Outcome; Young Adult	2017
Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Risk Factors; Treatment Outcome	2018
Sustained pediatric antimicrobial stewardship program with consultation to infectious diseases reduced carbapenem resistance and infection-related mortality. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017, Volume: 64 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Child; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Pseudomonas aeruginosa; Referral and Consultation; Tokyo	2017
The prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection. American journal of infection control, 2018, Volume: 46, Issue:2 Topics: Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Risk Factors	2018
Colistin Area Under the Time-Concentration in Children Treated With Intravenous Loading Dose and Maintenance Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 02-10, Volume: 66, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Child; Child, Preschool; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Injections, Intravenous; Underage Drinking	2018
Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy, 2018, Volume: 38, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Carbapenems; Cohort Studies; Drug Hypersensitivity; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Penicillins; Practice Patterns, Physicians'; Retrospective Studies; Time Factors	2018
Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy. Annals of hematology, 2018, Volume: 97, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Pneumonia; Prognosis; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination	2018
Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. The Journal of hospital infection, 2018, Volume: 98, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies	2018
β LACTA testing may not improve treatment decisions made with MALDI-TOF MS-informed antimicrobial stewardship advice for patients with Gram-negative bacteraemia: a prospective comparative study. Journal of medical microbiology, 2018, Volume: 67, Issue:2 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; beta-Lactamases; Carbapenems; Clinical Decision-Making; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization	2018
High excess costs of infections caused by carbapenem-resistant Gram-negative bacilli in an endemic region. International journal of antimicrobial agents, 2018, Volume: 51, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colombia; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Female; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Intraabdominal Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Surgical Wound Infection	2018
Prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection: Methodologic issues. American journal of infection control, 2018, Volume: 46, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Prospective Studies; Research Design; Risk Factors	2018
Response to a letter to the Editor regarding the prospective evaluation of risk factors and clinical influence of carbapenem resistance in children with gram-negative bacteria infection. American journal of infection control, 2018, Volume: 46, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Child; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Risk Factors	2018
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Surveys and Questionnaires	2018
[Identification of anaerobic gram-negative bacilli isolated from various clinical specimens and determination of antibiotic resistance profiles with E-test methods]. Mikrobiyoloji bulteni, 2018, Volume: 52, Issue:1 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2018
Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations. PloS one, 2018, Volume: 13, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cross Infection; Female; Germany; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; Treatment Outcome	2018
Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease? American journal of infection control, 2018, Volume: 46, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inpatients; Sepsis	2018
Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care. The Journal of hospital infection, 2018, Volume: 99, Issue:4 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Epidemiological Monitoring; Female; Gram-Negative Bacterial Infections; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Non-Randomized Controlled Trials as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Retrospective Studies; Young Adult	2018
Multicenter Evaluation of the Xpert Carba-R Assay for Detection of Carbapenemase Genes in Gram-Negative Isolates. Journal of clinical microbiology, 2018, Volume: 56, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Illinois; Italy; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Oregon; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Spain; Time Factors	2018
Integrons and insertion sequence common region 1 (ISCR1) of carbapenem-non-susceptible Gram-negative bacilli in fecal specimens from 5000 patients in southern China. International journal of antimicrobial agents, 2018, Volume: 52, Issue:5 Topics: beta-Lactam Resistance; Carbapenems; China; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Feces; Gene Order; Genes, Bacterial; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Integrons	2018
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Databases, Factual; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prognosis; Retrospective Studies; Treatment Outcome; United States; Young Adult	2018
Development and validation of a bedside instrument to predict carbapenem resistance among gram-negative pathogens in complicated urinary tract infections. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:9 Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Logistic Models; Male; Middle Aged; Models, Theoretical; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; United States; Urinary Tract Infections	2018
A prognostic score for the resolution of bacteremia by Gram-negative bacteria resistant to carbapenems. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Biomarkers; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Prognosis	2018
Warning: spread of NDM-1 in two border towns of Iran. Cellular and molecular biology (Noisy-le-Grand, France), 2018, Jul-30, Volume: 64, Issue:10 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacter; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Iran; Klebsiella pneumoniae	2018
Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2019, Volume: 52, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Chryseobacterium; Drug Resistance, Bacterial; Female; Flavobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Pseudomonas aeruginosa; Retrospective Studies; Stenotrophomonas maltophilia; Taiwan; Tertiary Care Centers	2019
Impact of an infectious diseases specialist-led antimicrobial stewardship programmes on antibiotic use and antimicrobial resistance in a large Korean hospital. Scientific reports, 2018, 10-03, Volume: 8, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Cephalosporins; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Fluoroquinolones; Glycopeptides; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Klebsiella pneumoniae; Physicians; Pseudomonas aeruginosa; Republic of Korea; Specialization; Staphylococcus aureus	2018
A carbapenem-resistant clinical isolate of Aeromonas hydrophila in Japan harbouring an acquired gene encoding GES-24 β-lactamase. Journal of medical microbiology, 2018, Volume: 67, Issue:11 Topics: Aeromonas hydrophila; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Bile; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Genome, Bacterial; Gram-Negative Bacterial Infections; Hospitalization; Humans; Japan; Microbial Sensitivity Tests; Sequence Analysis, DNA	2018
Carbapenem-resistant Gram-negative bloodstream infections in critically ill children: outcome and risk factors in a tertiary teaching hospital in South America. The Journal of hospital infection, 2019, Volume: 101, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Critical Illness; Female; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Infant; Male; Risk Factors; South America; Survival Analysis; Tertiary Care Centers; Treatment Outcome	2019
High frequency and molecular epidemiology of metallo-β-lactamase-producing gram-negative bacilli in a tertiary care hospital in Lahore, Pakistan. Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Pakistan; Public Health Surveillance; Tertiary Care Centers; Young Adult	2018
Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014. Antimicrobial resistance and infection control, 2018, Volume: 7 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Penicillins; Prevalence; Pseudomonas aeruginosa; Quinolones; Retrospective Studies; Tertiary Care Centers	2018
Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit. Medicina (Kaunas, Lithuania), 2018, Nov-26, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Bronchoalveolar Lavage; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Retrospective Studies; Risk Factors; Romania; Surgery Department, Hospital; Tertiary Healthcare	2018
Attributable clinical and economic burden of carbapenem-non-susceptible Gram-negative infections in patients hospitalized with complicated urinary tract infections. The Journal of hospital infection, 2019, Volume: 102, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cost of Illness; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Care Costs; Humans; Length of Stay; Male; Middle Aged; Prevalence; Survival Analysis; Urinary Tract Infections; Young Adult	2019
Novel Antibiotics in the Treatment of Urinary Tract Infections. European urology focus, 2019, Volume: 5, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Clinical Trials as Topic; Cystitis; Drug Resistance, Bacterial; Drug Therapy, Combination; Drug Utilization; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Iatrogenic Disease; Tetracyclines; Urinary Tract Infections	2019
Prevalence of metallo-β-lactamase acquired genes among carbapenems susceptible and resistant Gram-negative clinical isolates using multiplex PCR, Khartoum hospitals, Khartoum Sudan. BMC infectious diseases, 2018, Dec-17, Volume: 18, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Prevalence; Pseudomonas aeruginosa; Sudan	2018
Multidrug resistant Gram-negative infections in neonatology. Archivos argentinos de pediatria, 2019, 02-01, Volume: 117, Issue:1 Topics: Carbapenems; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies	2019
A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study. Chest, 2019, Volume: 155, Issue:6 Topics: Algorithms; beta-Lactam Resistance; Carbapenems; Costs and Cost Analysis; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Healthcare-Associated Pneumonia; Humans; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pneumonia, Ventilator-Associated; Retrospective Studies; Survival Analysis; United States	2019
Multiple colonization with carbapenem-resistant Gram-negative bacteria acquired in India and transferred to Switzerland. Infection, 2019, Volume: 47, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Middle Aged; Switzerland; Treatment Outcome	2019
Effect of short-term carbapenem restriction on the incidence of non-pseudomonal multi-drug resistant Gram-negative bacilli in an intensive care unit. Journal of chemotherapy (Florence, Italy), 2019, Volume: 31, Issue:5 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Saudi Arabia; Withholding Treatment	2019
Predicting acquisition of carbapenem-resistant Gram-negative pathogens in intensive care units. The Journal of hospital infection, 2019, Volume: 103, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Case-Control Studies; Clinical Decision Rules; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Risk Factors; Survival Analysis; Young Adult	2019
Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacilli Pathogens from Hospitals in Ghana. Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Genotype; Ghana; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Young Adult	2019
Forecasting models of infections due to carbapenem-resistant Gram-negative bacteria in an intensive care unit in an endemic area. Journal of global antimicrobial resistance, 2020, Volume: 20 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Bayes Theorem; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Models, Theoretical; Pseudomonas aeruginosa; Retrospective Studies; Seasons; Young Adult	2020
Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9 Topics: Achromobacter denitrificans; Acinetobacter; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromatography, Affinity; France; Gene Expression; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas; Sensitivity and Specificity; Species Specificity	2019
Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis. The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Ceftriaxone; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Intestines; Male; Meropenem; Middle Aged; Propensity Score; Retrospective Studies	2019
Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings? Expert review of anti-infective therapy, 2013, Volume: 11, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Communicable Disease Control; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Pseudomonas aeruginosa	2013
"Down the drain": carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. The Medical journal of Australia, 2013, Mar-18, Volume: 198, Issue:5 Topics: Australia; beta-Lactamases; Carbapenems; Confidence Intervals; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Equipment and Supplies, Hospital; Equipment Contamination; Female; Gram-Negative Bacterial Infections; Hand Disinfection; Humans; Incidence; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Risk Assessment	2013
Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance International journal of antimicrobial agents, 2013, Volume: 41, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence; Taiwan	2013
Detection of IMP metallo-β-lactamase in carbapenem-nonsusceptible Enterobacteriaceae and non-glucose-fermenting Gram-negative rods by immunochromatography assay. Journal of clinical microbiology, 2013, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromatography, Affinity; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA	2013
Risk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients. Intensive care medicine, 2013, Volume: 39, Issue:7 Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Greece; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors	2013
The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages. Pediatric pulmonology, 2014, Volume: 49, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Burkholderia cenocepacia; Burkholderia Infections; Carbapenems; Child; Cystic Fibrosis; Disease Progression; Doripenem; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Pseudomonas stutzeri; Rhodospirillaceae; Thienamycins; Tobramycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination	2014
Evaluation of brilliance CRE agar for the detection of carbapenem-resistant gram-negative bacteria. The new microbiologica, 2013, Volume: 36, Issue:2 Topics: Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2013
Emergence of VIM-6 metallo-beta-lactamase-producing Alcaligenes faecalis clinical isolates in a hospital in India. Journal of infection in developing countries, 2013, Jun-15, Volume: 7, Issue:6 Topics: Alcaligenes faecalis; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Gram-Negative Bacterial Infections; Hospitals; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA	2013
History of antibiotics: from fluoroquinolones to daptomycin (Part 2). Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2013, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Daptomycin; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; History, 20th Century; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Vancomycin	2013
Faecal carriage of ESBL-producing Enterobacteriaceae and carbapenem-resistant Gram-negative bacilli in community settings. Journal of infection in developing countries, 2013, Aug-15, Volume: 7, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Feces; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Young Adult	2013
Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH). BMC infectious diseases, 2013, Nov-06, Volume: 13 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, General; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Singapore; Thienamycins; Young Adult	2013
Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy. Scandinavian journal of infectious diseases, 2014, Volume: 46, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Polymyxin B; Prospective Studies; Renal Insufficiency; Rifampin; Survival Analysis; Treatment Outcome	2014
Carbapenem de-escalation therapy in a resource-limited setting. Infection control and hospital epidemiology, 2013, Volume: 34, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Female; Gentian Violet; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Lung Diseases; Male; Middle Aged; Phenazines; Referral and Consultation; Shock, Septic; Thailand; Urinary Tract Infections; Young Adult	2013
Risk factors and outcomes for multidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics, 2014, Volume: 133, Issue:2 Topics: Bacteremia; Carbapenems; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies; Risk Factors; Treatment Outcome	2014
Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea. Diagnostic microbiology and infectious disease, 2014, Volume: 78, Issue:4 Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Republic of Korea; Retrospective Studies; Risk Factors	2014
High-level and novel mechanisms of carbapenem resistance in Gram-negative bacteria from tertiary hospitals in Nigeria. International journal of antimicrobial agents, 2014, Volume: 43, Issue:5 Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Conjugation, Genetic; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Nigeria; Plasmids; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA; Tertiary Care Centers; Transformation, Bacterial	2014
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2013, Volume: 58, Issue:5-6 Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin	2013
NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; United Kingdom	2014
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011). Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam	2014
[Evolution of antimicrobial resistance in Gram negative bacilli from intensive care units in Colombia]. Biomedica : revista del Instituto Nacional de Salud, 2014, Volume: 34 Suppl 1 Topics: Acinetobacter baumannii; Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Colombia; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Intensive Care Units; Klebsiella pneumoniae; Population Surveillance; Pseudomonas aeruginosa	2014
Carbapenem and multidrug resistance in Gram-negative bacteria in a single centre in Italy: considerations on in vitro assay of active drugs. International journal of antimicrobial agents, 2014, Volume: 44, Issue:2 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Italy; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline	2014
Emergence of carbapenemase-producing Gram-negative bacteria in Saint Petersburg, Russia. International journal of antimicrobial agents, 2014, Volume: 44, Issue:2 Topics: Acinetobacter; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; DNA, Bacterial; Enterobacter cloacae; Genotype; Gram-Negative Bacterial Infections; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Russia	2014
Tracking colistin-treated patients to monitor the incidence and outcome of carbapenem-resistant Gram-negative infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Jan-01, Volume: 60, Issue:1 Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Colistin; Female; Gram-Negative Bacterial Infections; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; United States	2015
Risk factors for carbapenem resistant bacteraemia and mortality due to gram negative bacteraemia in a developing country. JPMA. The Journal of the Pakistan Medical Association, 2014, Volume: 64, Issue:5 Topics: Adult; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Male; Middle Aged; Multivariate Analysis; Pakistan; Prospective Studies; Risk Factors	2014
Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014, Dec-01, Volume: 59 Suppl 6 Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Michigan; Middle Aged; Minocycline; Pharmacy Service, Hospital	2014
Prevalence of carbapenem-resistant organisms and other Gram-negative MDRO in German ICUs: first results from the national nosocomial infection surveillance system (KISS). Infection, 2015, Volume: 43, Issue:2 Topics: Bacterial Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Germany; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Population Surveillance; Prevalence; Staphylococcal Infections; Vancomycin-Resistant Enterococci	2015
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. BMC infectious diseases, 2014, Nov-25, Volume: 14 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections	2014
Molecular characteristics of carbapenem-resistant gram-negative bacteria in southern China. Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:2 Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Genes, Bacterial; Glutathione Transferase; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Integrons; Meropenem; Mutagenesis, Insertional; Thienamycins	2015
Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Therapy; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Endemic Diseases; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Patient Readmission; Retrospective Studies; Survival Analysis; Treatment Outcome	2015
Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; London; Male; Middle Aged; Young Adult	2015
Prevalence and clinical burden of NDM-1 positive infections in pediatric and neonatal patients in Pakistan. The Pediatric infectious disease journal, 2015, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child, Preschool; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Pakistan; Polymerase Chain Reaction; Prevalence; Survival Analysis	2015
Next-generation sequencing of carbapenem-resistant Gram-negative microorganisms: a key tool for surveillance and infection control. Future microbiology, 2015, Volume: 10, Issue:3 Topics: beta-Lactam Resistance; Carbapenems; Epidemiological Monitoring; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Infection Control; Sequence Analysis, DNA	2015
Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study. PloS one, 2015, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Italy; Male; Middle Aged; Organ Transplantation; Risk Factors; Transplant Recipients	2015
Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Critical Illness; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Rate; Systemic Inflammatory Response Syndrome	2015
Outcome of Transplantation Using Organs From Donors Infected or Colonized With Carbapenem-Resistant Gram-Negative Bacteria. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015, Volume: 15, Issue:10 Topics: Adult; Aged; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Infant; Male; Middle Aged; Organ Transplantation; Retrospective Studies; Tissue Donors; Treatment Outcome	2015
Characterization of carbapenem-resistant Gram-negative bacteria from Tamil Nadu. Journal of chemotherapy (Florence, Italy), 2016, Volume: 28, Issue:5 Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Microbial Sensitivity Tests	2016
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis	2015
Prevalence of MRSA and Gram-negative bacteria with ESBLs and carbapenemases in patients from Northern Africa at a German hospital. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:11 Topics: Adult; Africa, Northern; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Genes, Bacterial; Genotype; Germany; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prevalence; Staphylococcal Infections; Transients and Migrants	2015
Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Prospective Studies; Pseudomonas aeruginosa; Sepsis; Survival Analysis	2016
Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Administration Schedule; Drug Dosage Calculations; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Treatment Outcome	2016
Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey. The Journal of hospital infection, 2016, Volume: 92, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Child; Child, Preschool; Drug Utilization; Female; Genotype; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Prospective Studies; Risk Factors; Tertiary Care Centers; Turkey	2016
Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital. The Journal of the Association of Physicians of India, 2015, Volume: 63, Issue:7 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Colistin; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Humans; India; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Tertiary Care Centers; Treatment Outcome; Young Adult	2015
First the ESBLs, now the Carbapenemases: Where will it End? The Journal of the Association of Physicians of India, 2015, Volume: 63, Issue:7 Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Gram-Negative Bacterial Infections; Humans; Male	2015
National epidemiology of carbapenem-resistant and extensively drug-resistant Gram-negative bacteria isolated from blood samples in China in 2013. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22 Suppl 1 Topics: Anti-Infective Agents; Carbapenems; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence	2016
Genotypic and phenotypic identification of Aeromonas species and CphA-mediated carbapenem resistance in Queensland, Australia. Diagnostic microbiology and infectious disease, 2016, Volume: 85, Issue:1 Topics: Aeromonas; Anti-Bacterial Agents; Australia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Genotype; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity	2016
Multiplex real-time PCR assay for the detection of extended-spectrum β-lactamase and carbapenemase genes using melting curve analysis. Journal of microbiological methods, 2016, Volume: 124 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Multiplex Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction	2016
Anatomic, Geographic, and Taxon-Specific Relative Risks of Carbapenem Resistance in the Health Care System of the U.S. Department of Defense. Journal of clinical microbiology, 2016, Volume: 54, Issue:6 Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Female; Geography; Gram-Negative Bacterial Infections; Health Facilities; Humans; Infant; Infant, Newborn; Male; Middle Aged; Military Facilities; Pseudomonas aeruginosa; Risk; United States; Young Adult	2016
Evaluation of Multiple Methods for Detection of Gastrointestinal Colonization of Carbapenem-Resistant Organisms from Rectal Swabs. Journal of clinical microbiology, 2016, Volume: 54, Issue:6 Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Rectum; Sensitivity and Specificity	2016
Carbapenem-resistant organisms (CRO): Information for patients, relatives and visitors. The Journal of hospital infection, 2016, Volume: 92, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Education; Humans	2016
Carbapenem-resistant organisms (CRO): Information for healthcare workers. The Journal of hospital infection, 2016, Volume: 92, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Utilization; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Health Personnel; Humans; Infection Control; Mass Screening	2016
Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012. Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Burn Units; Burns; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella; Klebsiella Infections; Linear Models; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Sweden; Urinary Tract Infections; Wound Infection; Young Adult	2016
Epidemiological characteristics and antimicrobial susceptibility among carbapenem-resistant non-fermenting bacteria in Brazil. Journal of infection in developing countries, 2016, Jun-30, Volume: 10, Issue:6 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Middle Aged; Polymerase Chain Reaction; Pseudomonas aeruginosa; Survival Analysis; Young Adult	2016
Boronic acid disk diffusion for the phenotypic detection of polymerase chain reaction-confirmed, carbapenem-resistant, gram-negative bacilli isolates. BMC microbiology, 2016, 07-01, Volume: 16, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Boronic Acids; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Phenotype; Polymerase Chain Reaction; Thienamycins	2016
High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs: A multi-centre point prevalence survey. Medicine, 2016, Volume: 95, Issue:27 Topics: Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Hospitals, Pediatric; Humans; Infant; Intensive Care Units, Pediatric; Male; Prevalence; Vietnam	2016
Carbapenem-resistant gram-negative bacilli in Tripoli, Libya. American journal of infection control, 2016, Oct-01, Volume: 44, Issue:10 Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Libya; Male; Middle Aged; Pseudomonas aeruginosa; Specimen Handling; Young Adult	2016
Screening for carbapenem-resistant organisms. The Journal of hospital infection, 2016, Volume: 94, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Disease Transmission, Infectious; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Mass Screening	2016
Improving outcomes in the management of Gram-negative bacterial infections in the face of growing antimicrobial resistance. Future microbiology, 2016, Volume: 11 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Congresses as Topic; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella; Netherlands; Population Surveillance; Pseudomonas aeruginosa; Risk Factors; Treatment Outcome	2016
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility. Infection control and hospital epidemiology, 2017, Volume: 38, Issue:1 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antimicrobial Stewardship; Carbapenems; Cross Infection; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Italy; Referral and Consultation; Rehabilitation Centers; Spinal Injuries	2017
The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Dec-15, Volume: 63, Issue:12 Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Health Status Indicators; Humans; Male; Mortality; Prospective Studies	2016
Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome. Diagnostic microbiology and infectious disease, 2017, Volume: 87, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Tertiary Care Centers	2017
Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series. Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Immunocompromised Host; Infant; Infant, Newborn; Japan; Male; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Young Adult	2017
Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study. BMC infectious diseases, 2008, Jun-09, Volume: 8 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Fever; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Neutropenia; Pakistan; Vancomycin Resistance	2008
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:12 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; United States	2008
Trends in Stenotrophomonas maltophilia bloodstream infection in relation to usage density of cephalosporins and carbapenems during 7 years. Infection control and hospital epidemiology, 2008, Volume: 29, Issue:10 Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Brazil; Carbapenems; Cephalosporins; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Stenotrophomonas maltophilia	2008
Antimicrobial activities of doripenem and other carbapenems against Pseudomonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Acinetobacter; Aeromonas; Anti-Bacterial Agents; Bacteria, Aerobic; Carbapenems; Doripenem; Gram-Negative Bacterial Infections; Humans; Latin America; Microbial Sensitivity Tests; North America; Pseudomonas	2009
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens. Diagnostic microbiology and infectious disease, 2009, Volume: 63, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2009
Antimicrobial resistance among and therapeutic options against gram-negative pathogens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Aug-15, Volume: 49 Suppl 1 Topics: beta-Lactamase Inhibitors; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2009
The emerging threat of acquired carbapenemases in Gram-negative bacteria. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Diseases, Emerging; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2010
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic	2010
Factors associated with recovery of multidrug-resistant bacteria in a combat support hospital in Iraq. Infection control and hospital epidemiology, 2010, Volume: 31, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Military; Humans; Iraq; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Military Personnel; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Warfare	2010
Mutant prevention concentrations of four carbapenems against gram-negative rods. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Phenotype; Pseudomonas aeruginosa; Thienamycins	2010
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method	2010
Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens. Journal of clinical microbiology, 2010, Volume: 48, Issue:9 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests	2010
Carbapenems in the treatment of intra-abdominal infection. Report from the 20th European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 10-13 April 2010. Future microbiology, 2010, Volume: 5, Issue:8 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Peritonitis	2010
In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: results of the COMPACT Asia-Pacific Study. International journal of antimicrobial agents, 2010, Volume: 36, Issue:6 Topics: Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pacific Islands; Thienamycins	2010
Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea. Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Korea; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Thienamycins; Urinary Tract Infections	2011
Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region. International journal of antimicrobial agents, 2011, Volume: 37, Issue:3 Topics: Anti-Bacterial Agents; Asia; Australia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Injections, Intravenous; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Thienamycins	2011
Frequency and susceptibility pattern of metallo-beta-lactamase producers in a hospital in Pakistan. Journal of infection in developing countries, 2010, Dec-23, Volume: 4, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Pakistan	2010
Emergence of metallo-β-lactamases and carbapenem resistance. Indian pediatrics, 2011, Volume: 48, Issue:2 Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Microbial Sensitivity Tests; Polymyxin B	2011
Comparative activity of carbapenem testing: the COMPACT study. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5 Topics: Africa; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Middle East; Thienamycins	2011
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins	2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey	2011
[Actual aspects of sepsis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:3-4 Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin	2011
Evaluation of doripenem utilization and susceptibilities at a large urban hospital. International journal of clinical pharmacy, 2011, Volume: 33, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Failure; Treatment Outcome; Urban Health Services; Young Adult	2011
Prevalence of New Delhi metallo-β-lactamase (NDM-1)-positive bacteria in a tertiary care centre in Pune, India. International journal of antimicrobial agents, 2012, Volume: 39, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Child; Drug Resistance, Bacterial; Female; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Young Adult	2012
Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints. Surgical infections, 2012, Volume: 13, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; South Africa	2012
Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study. The Journal of infection, 2012, Volume: 64, Issue:4 Topics: Aged; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Female; Fermentation; France; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Risk Factors; Stenotrophomonas maltophilia; Treatment Outcome	2012
Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Achromobacter denitrificans; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Chromosomes, Bacterial; DNA, Bacterial; Gram-Negative Bacterial Infections; Humans; Integrons; Kinetics; Libya; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Alignment; Sequence Homology, Amino Acid	2012
In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates. Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline	2012
Comparative activity of carbapenem testing (the COMPACT study) in Turkey. BMC infectious diseases, 2012, Feb-16, Volume: 12 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Turkey; Young Adult	2012
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Gram-Negative Bacterial Infections; Hospitals; Humans; Infection Control; Klebsiella pneumoniae; Length of Stay; New York City; Prevalence; Pseudomonas aeruginosa	2012
Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study. International journal of antimicrobial agents, 2012, Volume: 39, Issue:4 Topics: Anti-Bacterial Agents; Asia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Geography; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inhibitory Concentration 50; Intensive Care Units; Microbial Sensitivity Tests; Pacific Islands; Population Surveillance; Prevalence	2012
Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Molecular Typing; Plasmids; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA	2012
Successful treatment with doripenem of ventriculitis due to Achromobacter xylosoxidans. QJM : monthly journal of the Association of Physicians, 2014, Volume: 107, Issue:11 Topics: Achromobacter denitrificans; Adult; Anti-Bacterial Agents; Carbapenems; Cerebral Ventriculitis; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Treatment Outcome	2014
Proteomic analysis of clinical isolate of Stenotrophomonas maltophilia with blaNDM-1, blaL1 and blaL2 β-lactamase genes under imipenem treatment. Journal of proteome research, 2012, Aug-03, Volume: 11, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Gene Expression; Gene Expression Regulation, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Phenotype; Proteome; Proteomics; Stenotrophomonas maltophilia	2012
Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Amikacin; Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence; Prospective Studies; Urinary Tract Infections	2012
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9 Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Probability; Pseudomonas aeruginosa; Retrospective Studies; Survival Rate; Treatment Outcome	2012
[Last chance for effective antibiotics?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2012, Aug-21, Volume: 132, Issue:15 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Internationality; Norway	2012
Innate aminoglycoside resistance of Achromobacter xylosoxidans is due to AxyXY-OprZ, an RND-type multidrug efflux pump. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:1 Topics: Achromobacter denitrificans; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genes, MDR; Genome, Bacterial; Gram-Negative Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Respiratory Tract Infections; Sequence Analysis, DNA	2013
Pharmacodynamic profiling of doripenem, imipenem and meropenem against prevalent Gram-negative organisms in the Asia-Pacific region. International journal of antimicrobial agents, 2013, Volume: 41, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pacific Islands; Thienamycins; Time Factors	2013
Carbapenem disks on MacConkey agar in screening methods for detection of carbapenem-resistant Gram-negative rods in stools. Journal of clinical microbiology, 2013, Volume: 51, Issue:1 Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Culture Media; Feces; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests	2013
Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Animals; Anti-Bacterial Agents; Biological Availability; Carbapenems; Community-Acquired Infections; Dipeptidases; Dogs; Drug Stability; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rabbits; Rats; Rats, Sprague-Dawley	2013
Prosthetic aortic valve endocarditis due to Ochrobactrum anthropi. Indian journal of medical sciences, 2011, Volume: 65, Issue:2 Topics: Aged; Aortic Valve; Carbapenems; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Ochrobactrum anthropi	2011
Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children. The Pediatric infectious disease journal, 2013, Volume: 32, Issue:4 Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Hospitalized; Child, Preschool; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Pseudomonas; Pseudomonas Infections; Survival Analysis	2013
[Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria]. The Japanese journal of antibiotics, 2003, Volume: 56, Issue:5 Topics: Carbapenems; Cefozopran; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Monobactams; Penicillins; Product Surveillance, Postmarketing; Time Factors	2003
Genetic and biochemical characterization of a chromosome-encoded carbapenem-hydrolyzing ambler class D beta-lactamase from Shewanella algae. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Child; Chromosomes, Bacterial; Cloning, Molecular; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Female; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Phenotype; Plasmids; Shewanella	2004
Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2004, Volume: 37, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged	2004
In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8 Topics: Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Mice; Microbial Sensitivity Tests	2005
Incidence of carbapenem resistant nonfermenting gram negative bacilli from patients with respiratory infections in the intensive care units. Indian journal of medical microbiology, 2005, Volume: 23, Issue:3 Topics: beta-Lactam Resistance; Carbapenems; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; India; Intensive Care Units; Respiratory Tract Infections	2005
Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:10 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; beta-Lactams; Carbapenems; Drug Resistance, Microbial; Ertapenem; Gram-Negative Anaerobic Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Inhibitory Concentration 50; Metronidazole; Microbial Sensitivity Tests	2005
Detection of metallo beta-lactamase production and antibiotic resistance with E-test method in pseudomonas, acinetobacter and klebsiella strains, in Turkey. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2004, Volume: 10, Issue:5 Topics: Acinetobacter baumannii; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Turkey	2004
In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10 Topics: Abscess; Animals; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Enterococcus faecalis; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Infusions, Parenteral; Kinetics; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Molecular Structure; Reference Standards	2005
Acquired metallo-beta-lactamases: an increasing clinical threat. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-01, Volume: 41, Issue:11 Topics: Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2005
Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, Dec-01, Volume: 41, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged	2005
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. International journal of antimicrobial agents, 2005, Volume: 26, Issue:6 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Incidence; Length of Stay; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Taiwan	2005
Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003. The Southeast Asian journal of tropical medicine and public health, 2005, Volume: 36, Issue:6 Topics: beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Disease Susceptibility; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Prevalence; Risk Assessment; Risk Factors; Thailand; Treatment Outcome	2005
[Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002]. The Japanese journal of antibiotics, 2006, Volume: 59, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterococcus; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Pseudomonas aeruginosa; Staphylococcus; Staphylococcus aureus; Urinary Tract Infections	2006
Screening for antibiotic resistant Gram-negative bacteria. The Lancet. Infectious diseases, 2006, Volume: 6, Issue:6 Topics: Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control	2006
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics, 2006, Volume: 118, Issue:2 Topics: Blood; Candidiasis; Carbapenems; Catheterization, Central Venous; Central Nervous System Fungal Infections; Cephalosporins; Cerebrospinal Fluid; Comorbidity; Cross Infection; Enterocolitis, Necrotizing; Fungemia; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Prospective Studies; Registries; Risk Factors; Superinfection	2006
Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. Journal of clinical microbiology, 2006, Volume: 44, Issue:9 Topics: Acinetobacter; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Carbapenems; Culture Media; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Laboratories; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Pseudomonas; Sensitivity and Specificity	2006
Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). The Journal of hospital infection, 2006, Volume: 64, Issue:3 Topics: Anti-Bacterial Agents; Carbapenems; Ceftazidime; Drug Resistance, Bacterial; Drug Utilization Review; Fluoroquinolones; Germany; Glycopeptides; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Risk Factors; Sentinel Surveillance; Stenotrophomonas maltophilia	2006
In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals. Scandinavian journal of infectious diseases, 2006, Volume: 38, Issue:10 Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Enterobacteriaceae; Ertapenem; Gram-Negative Bacterial Infections; Humans; Imipenem; Klebsiella; Meropenem; Microbial Sensitivity Tests; Proteus; Sweden; Thienamycins	2006
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis. International journal of antimicrobial agents, 2007, Volume: 29, Issue:1 Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey	2007
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. Chest, 2006, Volume: 130, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Resistance, Multiple; Empiricism; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospitals, Teaching; Humans; Intensive Care Units; Male; Middle Aged; Missouri; Penicillins; Pneumonia, Bacterial; Prospective Studies; Survival Rate; Urinary Tract Infections; Ventilators, Mechanical	2006
Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2007, Volume: 26, Issue:1 Topics: Adult; Aged; Bacteremia; Carbapenems; Case-Control Studies; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Neoplasms; Neutropenia; Pneumonia, Bacterial; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Texas	2007
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2007, Volume: 39, Issue:12 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Infant; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests; Prospective Studies; Risk Factors	2007
One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India. Indian journal of medical microbiology, 2007, Volume: 25, Issue:3 Topics: Carbapenems; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Intensive Care Units; Microbial Sensitivity Tests	2007
[Resistance epidemiology of gramnegative nonfermenting pathogens of nosocomial infections in intensive care units and surgical departments]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:7 Topics: Acinetobacter baumannii; Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Moscow; Pseudomonas aeruginosa; Sulbactam; Surgery Department, Hospital	2006
[Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005]. Medycyna doswiadczalna i mikrobiologia, 2007, Volume: 59, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2007
Nosocomial bloodstream infection in a pediatric intensive care unit. Indian journal of pediatrics, 2008, Volume: 75, Issue:1 Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Medical Records; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Vancomycin	2008
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance. Critical care (London, England), 2008, Volume: 12 Suppl 4 Topics: Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans	2008
PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. Journal of clinical microbiology, 1996, Volume: 34, Issue:12 Topics: Alcaligenes; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Base Sequence; beta-Lactamases; Carbapenems; Ceftazidime; Cross Infection; DNA Primers; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Japan; Klebsiella pneumoniae; Molecular Epidemiology; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas putida; Serratia marcescens	1996
In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:3 Topics: Animals; Carbapenems; Cilastatin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Prodrugs; Protease Inhibitors; Sepsis	1998
The increase in carbapenem use and emergence of Stenotrophomonas maltophilia as an important nosocomial pathogen. Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:1 Topics: Bacteremia; Carbapenems; Cross Infection; Gram-Negative Bacterial Infections; Humans; Kuwait; Microbial Sensitivity Tests; Prospective Studies; Wound Infection; Xanthomonas	1999
Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms. Diagnostic microbiology and infectious disease, 1999, Volume: 34, Issue:1 Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillins	1999
Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs. Wiener klinische Wochenschrift, 1999, Jul-30, Volume: 111, Issue:14 Topics: Anti-Bacterial Agents; Austria; beta-Lactam Resistance; Carbapenems; Contraindications; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units	1999
Urinary tract infection in neurogenic bladder. International journal of antimicrobial agents, 2001, Volume: 17, Issue:4 Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections	2001
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, May-15, Volume: 32 Suppl 2 Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple; Europe; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Male; Microbial Sensitivity Tests; Middle Aged; Seasons; Stenotrophomonas maltophilia; United States	2001
Discordant carbapenem susceptibility in Methylobacterium species and its application as a method for phenotypic identification. Journal of clinical microbiology, 2001, Volume: 39, Issue:5 Topics: Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Meropenem; Methylobacterium; Microbial Sensitivity Tests; Phenotype; Thienamycins	2001
Nosocomial bloodstream infections in a Turkish university hospital: study of Gram-negative bacilli and their sensitivity patterns. International journal of antimicrobial agents, 2001, Volume: 17, Issue:6 Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; In Vitro Techniques; Turkey	2001